genericlicensing.com - featured companies 2011
DESCRIPTION
TRANSCRIPT
Global Generic
Product DirectoryFeatureD ComPanies
Edition 3, 2011
This is the 3rd ever edition of the
Global Generic Product DirectoryWe're really proud of this one. We've listened carefully to our community and made some changes. In this edition we have focused on presentingour recommended developers. Too much choice can be paralyzing; so you will now a FEATURED DEVELOPERS section at the front. We have alsoreplaced 25% of the developers for one's we consider better partners for your business.
Remember that you can find the contact details for all the listed developers online and its costs you nothing to make an enquiry.
:
Genericlicensing Limited has been set up to help you do more business, more effectively.We understand the industry is changing. We understand that you want to find new value-added products for new markets. During 2011 we willintroduce new data for: Biosimilars, Super Generics & Over-the-Counter
We want to be the first place you turn to when you think about a new productIn order to better support you and your business, we are working hard to introduce more services online. You can now ask us to post WANTEDproducts online so the developers can come to you! Enjoy the 3rd edition, we hope you will love, cherish and share it (ie tell other people about it!)
The world of generics at your fingertips!
Asa CoxFounder, Genericlicensing [email protected] skype: asa_cox
Legal: All the information contained in the directory has been provided by manufacturers and developers in good faith; Genericlicensing Limited cannot therefore guarantee the accuracy ofthe data. Any consequential loss cannot be accepted as a result of any business conducted with companies listed or their products.
Find a productyou like in thedirectory
Go online towww.genericlicensing.com
Make contact with the developer
FEATURED DEVELOPERSlisted alphabetically
Antiobiotic ........................ 1
Astron ........................ 2 – 8
Aurobindo ........................ 9 – 13
BluePharma ........................ 14
Chanelle Medical ........................ 15 – 16
FamyCare Ltd. ........................ 17
Farmaprojects ........................ 18 – 20
Hikma ........................ 21 – 39
LogenexPharm ........................ 40
Lupin ........................ 41 – 44
Naari ........................ 45
Neogen ........................ 46
Orion ........................ 47
Rivopharm ........................ 48
Technimede ........................ 49 – 52
Wockhardt ........................ 53 – 59
Worwag ........................ 60
Contents
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
because timing is everythingWe target our goals.
target our drugs. time our delivery…
For more information please visit www.dexcel.com Contact: [email protected], [email protected]
Research:groups of patents.Development: Approximately 50 products registered; about 20 further in development.Capacity: 3 manufacturing facilities – cutting-edge, computer-controlled manufacturing technology – including electronic batch recording.Quality: and
transfer and inventory coverage.Responsiveness: Global supply chain management services. Marketing/ Distribution: Major generic player in UK and Israel; fully geared up to win tenders in Germany. Presence in several more markets worldwide via distribution partners.
Interested in: Contract manufacturing Contract development/ Co-development Out-licencing In-licencing Distribution EU-re-analyses/ release
FEATUREDDEVELOPERS
1
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
COUNTRYBulgaria
CITYRazgad
COMPANY NAMEAntibiotic
Antibiotic - Razgrad JSC, as the successor of the largest producer of antibiotics in Bulgaria. Balkanpharma-Razgrad JSC, has over 50 years experience in the development, production and sales of generic medicines for human and veterinary use. Antibiotic - Razgrad JSC is the majority owner of Balkanpharma-Razgrad JSC - a pharmaceutical plant with production units for finished dosage forms: capsules and tablets, semi-solid dosage forms, sterile liquid and dry injectable forms and also an industrial unit for lyophilized APIs. The portfolio of products covers various therapeutic areas with an accent on infectious diseases, ophthalmology and dermatology. Antibiotic - Razgrad JSC has the necessary manufacture licenses and EU GMP certification for all productions and currently exports to more than 25 countries in Europe and Asia. The development strategy of the company includes the implementation of modern technologies and new products elaborated by its own R&D activities and is oriented towards expanding sales in international markets. Apart from own market presence, the company is open to out-licensing and contract manufacturing projects.
Core Sales Territory: Eastern EuropeCore Operation: API Manufacture, Finished Dose Manufacture, Sales and MarketingContact Person: Ms Gergana Semova; Managing Director
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Betamethasone + Gentamicin Cream 1 mg + 1 mg CTD Ready Bulgaria PLGBetamethasone + Gentamicin Ointment 1 mg + 1 mg CTD Ready Bulgaria PLGBetamethasone Valerate Cream 1 mg / g CTD Ready Bulgaria PLGBetamethasone Valerate Ointment 1 mg / g CTD Ready Bulgaria PLGDexamethasone Tablet 0.5 mg CTD Ready Bulgaria PLGFluconazole Injection - Solution 2 mg/ml - 50 ml, 100 ml CTD Ready Bulgaria PLGFluconazole Capsule 150 mg eCTD In-Dev BulgariaFluconazole Capsule 200 mg eCTD In-Dev BulgariaGentamicin Ointment - Eye 3 mg / g CTD Ready Bulgaria PLGHydrocortison + Chloramphenicol Ointment - Eye 5 mg/g + 2 mg/g CTD Ready Bulgaria PLGLevofloxacin Injection - Solution 5 mg/ml - 50 ml CTD Ready Bulgaria PLGLevofloxacin Injection - Solution 5 mg/ml - 100 ml CTD Ready Bulgaria PLGLevofloxacin Drops - Eye 5 mg/ml - 5 ml CTD Ready Bulgaria PLGMethylprednisolone Tablet 4 mg CTD Ready Bulgaria PLGMethylprednisolone Tablet 4 mg CTD Ready Bulgaria PLGPrednisolone Tablet 5 mg CTD Ready Bulgaria PLGPrednisone Tablet 5 mg CTD Ready Bulgaria PLGTobramycin Ointment - Eye 3 mg/g CTD Ready Bulgaria PLGTobramycin + Dexamethasone Ointment - Eye 3 mg/g + 1 mg/g CTD Ready Bulgaria PLG
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)2
COUNTRYIndia
CITYAhmedabad
COMPANY NAMEAstron Research Ltd
Astron Research Ltd was established in the year 2001 with an objective to provide prompt and reliable services to Pharma sector worldwide and improve the product quality with the help of Technological Innovations and Upgradations. Astron commenced its UK operations in 2004 for Quality Testing and QP Release of finished formulations and API. This facility is now UK-MHRA approved.Astron Research Ltd has products and technology are sold in over 50 countries, which includes European Union, US, Canada Austra-lia, New Zealand, South Africa, Brazil, Mexico, Middle East & North African countries. 18 ANDAs filed in US and 38 EU CTD dossiers developed till 2007. Astron Research Ltd is capable of handling Formulation and Analytical Research of Solid Orals, Injectables, Lyophilised injectables, Topicals, Effervescent tablets, Specialty medicaments like Potent drugs & Oncology products. The company has also acquired expertise in oral NDDS and Controlled Release pellets.Core Sales Territory: Global Regulated MarketsCore Operation: API Manufacture, Finished Dose Manufacture, Sales and Marketing, Distribution Contact Person: Marc Comas, VP Business Development
Molecule name DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Aceclofenac Tablet - Film coated 100 mg CTD Ready Spain PLG
Alendronate / Alendronic Acid Tablet 5 mg, 10 mg, 70 mg CTD Ready IOR PLG
Anastrozole Tablet - Film coated 1 mg ANDA Ready IOR NRP
Anastrozole Tablet - Film coated 1 mg CTD Ready IOR PLG
Aripiprazole Tablet - Dispersible (ODT) 5 mg, 10 mg, 15 mg, 30 mg CTD In-Dev N / A DCP slot booked
Aripiprazole Tablet - Dispersible (ODT) 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg ANDA In-Dev N / A NRP
Atorvastatin Tablet 10 mg, 20 mg, 40 mg, 80 mg CTD In-Dev N / A NRP
Atorvastatin Tablet 10 mg, 20 mg, 40 mg, 80 mg ANDA In-Dev N / A NRP
Bicalutamide Tablet - Film coated 50 mg CTD Ready IOR PLG
Bicalutamide Tablet - Film coated 50 mg ANDA Ready IOR PLG
Bisoprolol Tablet 2.5 mg, 5 mg, 10 mg CTD In-Dev N / A DCP slot booked
Calcium Carbonate Tablet - Effervescent 500 mg CTD Ready IOR DCP underway
Candesartan Tablet 2 mg, 4 mg, 8 mg, 16 mg, 32 mg CTD In-Dev N / A NRP
Capecitabine Tablet - Film coated 150 mg, 500 mg CTD In-Dev N / A DCP slot booked
Carbidopa + Levodopa Tablet - SR 50 mg + 200 mg, 25 mg + 100 mg CTD In-Dev N / A NRP
Carbidopa + Levodopa Tablet - SR 50 mg + 200 mg, 25 mg + 100 mg ANDA In-Dev N / A NRP
Carboplatin Injection 10 mg / ml (5 ml, 15 ml, 45 ml vials) ANDA In-Dev N / A NRP
Carboplatin Injection 10 mg/ml (60 ml) CTD Ready IOR NRP
Carboplatin Injection 10 mg / ml (5 ml, 15 ml, 45 ml vials) CTD Ready IOR PLG
Cisplatin Injection - Solution 1 mg/ml (100 ml) CTD Ready IOR NRP
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission. 3
Molecule name DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Cisplatin Injection - Solution 1 mg/ml (10 ml, 25 ml, 50 ml) CTD Ready IOR PLG
Clopidogrel Tablet 75 mg ANDA In-Dev N / A NRP
Clopidogrel Hydrogenbisulphat Tablet 75 mg CTD Ready IOR DCP underway
Clozapine Capsule - XR 25 mg, 50 mg, 100 mg, 200 mg CTD In-Dev N / A NRP
Cytarabine Injection 100 mg/ml (1 ml, 5 ml, 10 ml) CTD Ready IOR PLG
Darifenacin Tablet - SR 7.5 mg, 15 mg CTD In-Dev N / A NRP
Docetaxel Injection 40 mg/ml (0.5 ml, 2 ml) CTD Ready IOR DCP underway
Docetaxel Injection 40 mg/ml (0.2 ml, 0.8 ml) ANDA Ready IOR NRP
Donepezil Tablet 5 mg, 10 mg CTD Ready IOR PLG
Donepezil Tablet 5 mg, 10 mg ANDA Ready IOR NRP
Doxorubicin Injection - Solution 2 mg/ml (5 ml, 25 ml, 100 ml) CTD Ready UK PLG
Enoxaparin Injection - Pre-filled syringe150 mg, 300 mg (3 ml), 0.2 ml, 0.4 ml, 0.6 ml, 0.8 ml, 1 ml
CTD In-Dev N / A NRP
Enoxaparin Injection - Pre-filled syringe150 mg, 300 mg (3 ml), 0.2 ml, 0.4 ml, 0.6 ml, 0.8 ml, 1 ml
ANDA In-Dev N / A NRP
Epirubicin Injection - Solution 2 mg/ml (5 ml, 10 ml, 25 ml, 100 ml) ANDA In-Dev N / A NRP
Epirubicin Injection - Solution 2 mg/ml (5 ml, 10 ml, 25 ml, 100 ml) CTD Ready IOR PLG
Escitalopram Tablet 10 mg, 20 mg, 40 mg CTD Ready IOR PLG
Etoposide Injection 20 mg/ml (12.5 ml, 25 ml) ANDA Ready IOR NRP
Exemestane Tablet 25 mg CTD Ready IOR PLG
Exemestane Tablet 25 mg ANDA In-Dev N / A NRP
Fesoterodine Tablet - SR 4 mg, 8 mg CTD In-Dev N / A NRP
Finasteride Tablet 1 mg CTD Ready IOR PLG
Finasteride Tablet 5 mg CTD Ready IOR PLG
Finasteride Tablet 1 mg ANDA Ready IOR NRP
Finasteride Tablet 5 mg ANDA Ready IOR PLG
Fludarabine Injection 50 mg/ml (2ml) ANDA Ready IOR NRP
ASTRON RESEARCH LTD
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)4
Molecule name DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Fluorouracil (5FU) Injection 50 mg/ml (5 ml, 10 ml, 20 ml, 100 ml) ANDA In-Dev N / A NRP
Fluorouracil (5FU) Injection 50 mg/ml (5 ml, 10 ml, 20 ml, 100 ml) CTD Ready IOR PLG
Fluvastatin Tablet - SR 80 mg CTD In-Dev N / A DCP slot booked
Fluvastatin Tablet - SR 80 mg ANDA In-Dev N / A NRP
Gabapentin Tablet - Film coated 600 mg, 800 mg CTD Ready Finland PLG
Gemcitabine Injection - Ready-to-use 0.2 g, 1 g, 1.5 g, 2 g CTD In-Dev N / A DCP underway
Gemcitabine Injection - Powder 2000 mg CTD Ready IOR DCP slot booked
Gemcitabine Injection - Powder 200 mg, 1000 mg CTD Ready IOR PLG
Gemcitabine Injection - Powder 200 mg, 1000 mg, 2000 mg ANDA Ready IOR NRP
Glimepiride Tablet 1 mg, 2 mg, 3 mg, 4 mg CTD Ready IOR PLG
Glimepiride Tablet 1 mg, 2 mg, 4 mg ANDA Ready IOR PLG
Imatinib Tablet 100 mg, 400 mg CTD In-Dev N / A DCP slot booked
Irbesartan Tablet 75 mg, 150 mg, 300 mg CTD Ready IOR PLG
Irinotecan Injection 20 mg/ml (2 ml, 5 ml) CTD Ready IOR PLG
Irinotecan Injection 20 mg/ml (2 ml, 5 ml) ANDA In-Dev N / A NRP
Irinotecan Injection 20 mg/ml (25 ml) CTD Ready IOR NRP
Iron Sucrose Injection 20 mg/ml (5 ml vial) ANDA In-Dev N / A NRP
Lansoprazole Tablet - Enteric coated 15 mg, 30 mg CTD In-Dev N / A DCP slot booked
Lansoprazole Capsule - SR 15 mg, 30 mg ANDA In-Dev N / A NRP
Letrozole Tablet - Film coated 2.5 mg CTD Ready IOR PLG
Letrozole Tablet - Film coated 2.5 mg ANDA Ready IOR PLG
Levetiracetam Tablet 250 mg, 500 mg, 750 mg, 1000 mg CTD Ready IOR DCP slot booked
Levetiracetam Tablet 250 mg, 500 mg, 750 mg, 1000 mg ANDA Ready N / A Approved
Levodopa + Carbidopa Tablet 100 mg + 25 mg, 200 mg + 50 mg CTD Ready N / A DCP underway
Levodopa + Carbidopa Tablet 100 mg + 25 mg, 200 mg + 50 mg ANDA In-Dev N / A NRP
Levofloxacin Tablet 250 mg, 500 mg CTD Ready N / A DCP underway
Levothyroxine Tablet 25/50/75/88/100/112/125/137/150/175/200/300 µg CTD In-Dev N / A NRP
ASTRON RESEARCH LTD
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission. 5
Molecule name DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Levothyroxine Tablet 25/50/75/88/100/112/125/137/150/175/200/300 µg ANDA In-Dev N / A NRP
Losartan Potassium Tablet - Film coated 25 mg, 50 mg, 100 mg CTD Ready IOR PLG
Meloxicam Injection 5 mg/ml (10 ml) ANDA Ready IOR NRP
Methotrexate Injection 5 mg/ml (3 ml) CTD Ready Sweden PLG
Methotrexate Injection 25 mg/ml (2ml) CTD Ready IOR NRP
Methotrexate Injection 100 mg/ml (5 ml, 10 ml) CTD Ready IOR NRP
Methotrexate Injection 5 mg/ml (3 ml) ANDA In-Dev N / A NRP
Methotrexate Injection 25 mg/ml (2ml) ANDA In-Dev N / A NRP
Methotrexate Injection 100 mg/ml (5 ml, 10 ml) ANDA In-Dev N / A NRP
Methotrexate Injection 25 mg/ml (20 ml. 40 ml) CTD Ready IOR NRP
Metoprolol Succinate Tablet - SR 25 mg, 50 mg, 100 mg, 200 mg ANDA Ready IOR NRP
Midazolam Injection 1 mg/ml (5 ml) CTD Ready IOR PLG
Midazolam Injection 5 mg/ml (1 ml, 3 ml, 10 ml) CTD Ready IOR PLG
Mitomycin Injection - Powder 5 mg, 20 mg, 40 mg ANDA Ready IOR PLG
Mitomycin Injection - Powder 0.2 mg/vial ANDA In-Dev N / A NRP
Mitoxantrone Injection 2 mg/ml (10 ml, 12.5 ml, 15 ml) ANDA In-Dev N / A NRP
Montelukast Tablet - Chewable 4 mg, 5 mg CTD Ready Europe PLG
Montelukast Tablet - Film coated 10 mg CTD In-Dev N / A DCP underway
Montelukast Tablet - Film coated 10 mg ANDA In-Dev N / A NRP
Mycophenelate Mofetil Injection - Powder 500 mg CTD In-Dev N / A DCP underway
Mycophenelate Mofetil Capsule - Hard gel 250 mg ANDA Ready IOR PLG
Mycophenelate Mofetil Capsule - Hard gel 250 mg CTD Ready IOR PLG
Mycophenelate Mofetil Tablet - Film coated 500 mg CTD Ready IOR PLG
Mycophenelate Mofetil Tablet - Film coated 500 mg ANDA Ready IOR PLG
Naltrexone Tablet 50 mg CTD Ready UK PLG
Naltrexone Tablet 50 mg ANDA Ready IOR NRP
Olanzapine Tablet 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg CTD Ready IOR DCP underway
ASTRON RESEARCH LTD
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)6
Molecule name DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Olanzapine Tablet 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg ANDA In-Dev N / A NRP
Olmasertan Tablet 5 mg, 10 mg, 20 mg, 40 mg CTD In-Dev N / A DCP slot booked
Omeprazole Capsule 20 mg, 40 mg CTD In-Dev N / A DCP slot booked
Ondansetron Injection 2 mg/ml (2 ml, 4 ml) CTD Ready IOR PLG
Ondansetron Injection 2 mg/ml (2 ml, 4 ml) ANDA In-Dev N / A NRP
Orlistat Capsule 60 mg CTD In-Dev N / A NRP
Oxaliplatin Injection - Powder 50 mg, 100 mg CTD Ready IOR PLG
Oxaliplatin Injection - Ready-to-use 50 mg, 100 mg CTD Ready IOR PLG
Oxaliplatin Injection - Ready-to-use 5 mg/ml (10 ml, 20 ml, 40 ml) ANDA In-Dev N / A NRP
Oxaliplatin Injection - Ready-to-use 200 mg CTD Ready IOR NRP
Oxcarbazepine Capsule - XR 300 mg, 600 mg CTD In-Dev N / A NRP
Oxybutynin Tablet - SR 5 mg, 10 mg, 15 mg CTD In-Dev N / A NRP
Paclitaxel Injection - Solution 6 mg/ml (5 ml, 16.7 ml, 50 ml) CTD Ready IOR DCP underway
Paclitaxel Injection - Solution 6 mg/ml (5 ml, 16.7 ml, 50 ml) ANDA Ready IOR NRP
Paliperidone Tablet - SR 1.5 mg, 3 mg, 6 mg, 9 mg ANDA In-Dev N / A NRP
Pantoprazole Sodium Tablet - Enteric coated 20 mg, 40 mg CTD In-Dev N / A DCP slot booked
Pantoprazole Sodium Tablet - SR 20 mg, 40 mg ANDA In-Dev N / A NRP
Paracetamol Tablet - Effervescent 500 mg, 1000 mg CTD Ready IOR PLG
Pemetrexed Injection - Powder 100 mg, 500 mg CTD In-Dev N / A DCP slot booked
Pioglitazone Tablet 15 mg, 30 mg, 45 mg CTD Ready IOR DCP slot booked
Pioglitazone Tablet 15 mg, 30 mg, 45 mg ANDA Ready IOR NRP
Pramipexole Tablet 125 µg, 250 µg, 500 µg, 1000 µg, 1500 µg CTD In-Dev N / A NRP
Pramipexole Tablet 125 µg, 250 µg, 500 µg, 1000 µg, 1500 µg ANDA In-Dev N / A NRP
Pravastatin Tablet 10 mg, 20 mg, 40 mg CTD Ready IOR PLG
Pravastatin Tablet 10 mg, 20 mg, 40 mg, 80 mg ANDA In-Dev N / A NRP
Pregabalin Capsule25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, 300 mg
CTD In-Dev N / A NRP
ASTRON RESEARCH LTD
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission. 7
Molecule name DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Quetiapine Tablet - SR 200 mg, 300 mg, 400 mg CTD Ready IOR DCP underway
Quetiapine Tablet - IR 25 mg, 100 mg, 150 mg, 200 mg, 300 mg CTD Ready IOR DCP underway
Quetiapine Tablet - SR 50 mg CTD In-Dev N / A DCP slot booked
Quetiapine Tablet - IR 25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg ANDA In-Dev N / A NRP
Quetiapine Tablet - SR 150 mg, 200 mg, 300 mg, 400 mg ANDA Ready IOR NRP
Quetiapine Tablet - SR 50 mg ANDA In-Dev N / A NRP
Quinine Sulphate Tablet 300 mg CTD Ready IOR NRP
Rabeprazole Tablet 10 mg, 20 mg CTD In-Dev N / A DCP slot booked
Ramipril Tablet 1.25 mg, 2.5 mg, 5 mg, 10 mg CTD In-Dev N / A DCP underway
Ranitidine Tablet - Effervescent 150 mg, 300 mg CTD Ready IOR PLG
Ranitidine Tablet - Effervescent 75 mg CTD In-Dev N / A NRP
Rasagiline Tablet 1 mg CTD In-Dev N / A NRP
Repaglinide Tablet 0.5 mg, 1 mg, 2 mg CTD In-Dev N / A DCP slot booked
Risperidone Tablet - Film coated 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg CTD Ready IOR PLG
Ropinirole Tablet - Film coated 0.25 mg, 0.5 mg, 1 mg, 2 mg, 5 mg CTD Ready IOR PLG
Sildenafil Tablet 25 mg, 50 mg, 100 mg CTD Ready IOR DCP underway
Simvastatin Tablet - Film coated 10 mg, 20 mg, 40 mg, 80 mg ANDA Ready IOR PLG
Sirolimus Tablet 1 mg, 2 mg CTD In-Dev N / A DCP slot booked
Sodium Valproate Tablet - SR 300 mg, 500 mg CTD In-Dev N / A NRP
Solifenacin succinate Tablet - Film coated 5 mg, 10 mg CTD In-Dev N / A DCP slot booked
Sumatriptan Succinate Tablet 50 mg, 100 mg CTD Ready Finland PLG
Tacrolimus Capsule - Hard gel 0.5 mg, 1 mg, 5 mg CTD Ready IOR DCP underway
Tacrolimus Capsule - Hard gel 0.5 mg, 1 mg, 5 mg ANDA Ready IOR NRP
Tacrolimus Ointment 0.01%, 0.03% CTD In-Dev N / A NRP
Tadalafil Tablet 2.5 mg, 5 mg, 10 mg, 20 mg CTD In-Dev N / A DCP slot booked
Telmisartan Tablet 20 mg, 40 mg, 80 mg CTD In-Dev N / A DCP slot booked
Telmisartan + HCTZ Tablet 40 mg + 12.5 mg, 80 mg + 12.5 mg CTD In-Dev N / A NRP
ASTRON RESEARCH LTD
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)8
Molecule name DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Temozolomide Capsule - Hard gel 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg CTD Ready IOR NRP
Temozolomide Capsule - Hard gel 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg ANDA Ready IOR NRP
Terazosin Tablet 1 mg, 2 mg, 5 mg, 10 mg CTD Ready IOR PLG
Tolterodine Capsule - XR 2 mg, 4 mg CTD In-Dev N / A DCP slot booked
Tolterodine Capsule - SR 4 mg ANDA In-Dev N / A NRP
Tolterodine Tablet - IR 1 mg, 2 mg CTD Ready IOR PLG
Topiramate Tablet 25 mg, 50 mg, 100 mg, 200 mg CTD Ready IOR PLG
Topotecan Injection - Powder 4 mg CTD Ready IOR PLG
Topotecan Injection - Ready-to-use 4 mg CTD In-Dev N / A NRP
Vardenafil Tablet - Film coated 5 mg, 10 mg, 20 mg CTD In-Dev N / A NRP
Vitamin C Tablet - Effervescent 500 mg CTD In-Dev N / A NRP
Voriconazole Tablet 50/200 mg CTD In-Dev N / A NRP
Warfarin Tablet1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg, 10 mg
CTD In-Dev N / A DCP slot booked
Warfarin Tablet1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg, 10 mg
ANDA Ready IOR NRP
Ziprasidone Capsule 20 mg, 40 mg, 60 mg, 80 mg CTD In-Dev N / A NRP
ASTRON RESEARCH LTD
9
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
COMPANY NAMEAurobindo
COUNTRYIndia
CITYHyderabad
Aurobindo Pharma was born of a vision. The company is the market leader in semi-synthetic penicillin drugs. It has a presence in key therapeutic segments like SSPs, cephalosporins, antivirals, CNS, cardiovascular, gastroenterology, etc. Over the years, the Au-robindo Pharma has evolved into a knowledge driven company. It is R&D focused, has a multi-product portfolio with multi-country manufacturing facilities, and is becoming a marketing conglomerate across the world. Aurobindo Pharma created a name for itself in the manufacture of bulk actives, its area of core competence. The formulation busi-ness is systematically organized with a divisional structure, and has a focused team for each key international market. Aurobindo believes in gaining volume and market share in every business/segment it enters. Core Sales Territory: Global Regulated MarketsCore Operation: API Manufacture, Finished Dose Manufacture, Sales and Marketing, DistributionContact Person: Mr Vivek Shah; Business Support Manager
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Alendronate sodium Tablet 10, 70 mg; CTD Ready IOR IOR
Alendronate sodium + Cholecalciferol Tablet 70mg+2800IU, 70mg+5600IU CTD Ready IOR IOR
Alfuzosin HCl Tablet - XR 10 mg CTD Ready IOR IOR
Alfuzosin HCl Tablet 2.5mg CTD Ready IOR IOR
Alprazolam Tablet 0.25,0.5,1mg CTD Ready IOR IOR
Amisulpride Tablet 50, 100, 200, 400mg CTD Ready IOR IOR
Amlodipine Tablet 5&10 mg; CTD Ready IOR IOR
Amlodipine Capsule 5,10mg CTD Ready IOR IOR
Amoxicillin Capsule 250,500mg CTD Ready IOR IOR
Amoxicillin Tablet 1G CTD Ready IOR IOR
Amoxicillin + Clavulanic Acid PFOS 125+31.25, 250+62.5 mg: Sugar free CTD Ready IOR IOR
Azithromycin Suspension - Oral 200mg/5ml, 500mg/5ml* CTD Ready IOR IOR
Azithromycin Tablet 250/500/600mg CTD Ready IOR IOR
Benazepril Tablet 5, 10, 20mg CTD Ready IOR IOR
Betahistine Tablet 8,16,24mg CTD Ready IOR IOR
Bisoprolol Fumarate Tablet 1.25,2.5,3.75,5mg CTD Ready IOR IOR
Carvedilol Tablet 3.125,6.25,12.5,25mg CTD Ready IOR IOR
Cefixime Suspension - Oral 100mg/5ml CTD Ready IOR IOR
Cefixime Tablet 200,400mg CTD Ready IOR IOR
AUROBINDO PHARMA
10
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Cefpodoxime Proxetil Suspension - Oral 40mg/5ml CTD Ready IOR IOR
Cefpodoxime Proxetil Tablet 100, 200mg CTD Ready IOR IOR
Cefprozil PFOS 125, 250mg/5ml CTD Ready IOR IOR
Cefprozil Tablet 250, 500mg CTD Ready IOR IOR
Cefuroxime Axetil Tablet 250,500mg; UK, PL 125 mg CTD Ready IOR IOR
Cephalexin Capsule 250,500mg CTD Ready IOR IOR
Cetirizine HCl Tablet 10 mg CTD Ready IOR IOR
Ciprofloxacin HCl Tablet 250,500,750mg CTD Ready IOR IOR
Citalopram HBr Tablet 10,20,40 mg CTD Ready IOR IOR
Clarithromycin Tablet 250,500mg CTD Ready IOR IOR
Clindamycin HCl Capsule 150, 300 mg CTD Ready IOR IOR
Cloxacillin Capsule 250, 500mg CTD Ready IOR IOR
Didanosine Capsule - EC 200250400 CTD Ready IOR IOR
Doxazosin Mesylate Tablet 1,2,4,8mg CTD Ready IOR IOR
Enalapril Maleate Tablet 5, 10, 20mg CTD Ready IOR IOR
Esomeprazole Magnesium Tablet - DR 20,40mg CTD Ready IOR IOR
Finasteride Tablet 5mg CTD Ready IOR IOR
Finasteride Tablet 1mg CTD Ready IOR IOR
Fluconazole Suspension - Oral 50, 200 mg / 5ml, CTD Ready IOR IOR
Fluconazole Capsule 50,100,150,200mg CTD Ready IOR IOR
Fluoxetine HCl Solution - Oral 20mg/5ml CTD Ready IOR IOR
Fluoxetine HCl Capsule 10, 20, 40, 60mg CTD Ready IOR IOR
Fosinopril + HCTZ Tablet 20+12.5mg CTD Ready IOR IOR
Fosinopril Sodium Tablet 10, 20 mg CTD Ready IOR IOR
Furosemide Tablet 20, 40mg CTD Ready IOR IOR
Gabapentin Capsule 100,300,400mg CTD Ready IOR IOR
Gabapentin Tablet 600,800mg; CTD Ready IOR IOR
AUROBINDO PHARMA
11
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Glimepiride Tablet 1,2,3,4mg CTD Ready IOR IOR
Lamotrigine Tablet 25, 50, 100, 200 mg CTD Ready IOR IOR
Lamotrigine Tablet - Chewable 2, 5, 25, 50, 100, 200mg CTD Ready IOR IOR
Lansoprazole Capsule - DR 15,30mg CTD Ready IOR IOR
Lansoprazole Tablet - Dispersible (ODT) 15, 30 mg CTD Ready IOR IOR
Levetiracetam Solution - Oral 100mg/ml CTD Ready IOR IOR
Levetiracetam Tablet 250,500,750mg, 1g CTD Ready IOR IOR
Lisinopril Tablet 5, 10, 20, 30, 40 mg CTD Ready IOR IOR
Lisinopril + HCTZ Tablet 10+12.5,20+12.5mg CTD Ready IOR IOR
Losartan Potassium Tablet 12.5, 25, 50, 100mg CTD Ready IOR IOR
Losartan Potassium + HCTZ Tablet 50+12.5, 100+25mg CTD Ready IOR IOR
Meloxicam Tablet 7.5,15mg CTD Ready IOR IOR
Metformin HCl Tablet 500,850,1000mg CTD Ready IOR IOR
Metoprolol Tartrate Tablet 50,100 & 200MG CTD Ready IOR IOR
Mirtazapine Tablet - Dispersible (ODT) : 15, 30, 45mg CTD Ready IOR IOR
Mirtazapine Plain Tablet 15,30,45mg CTD Ready IOR IOR
Modafinil Tablet 100 mg CTD Ready IOR IOR
Moxifloxacin HCl Tablet 400mg CTD Ready IOR IOR
Naproxen Tablet 250, 500mg CTD Ready IOR IOR
Naproxen Sodium Tablet 550mg CTD Ready IOR IOR
Nevirapine TFOS 50 mg PEPFAR PED CTD Ready IOR IOR
Nevirapine Tablet 200mg CTD Ready IOR IOR
Nitrofurantoin Capsule 100mg (75mg MH + 25 Mcryst) CTD Ready IOR IOR
Olanzapine Tablet 2.5, 5, 7.5, 10, 15, 20 mg CTD Ready IOR IOR
Olanzapine Tablet - Dispersible (ODT) 5,10,15,20 mg CTD Ready IOR IOR
Omeprazole Pellet - DR 10,20,40mg CTD Ready IOR IOR
Ondansetron Tablet - Dispersible (ODT) 4,8mg CTD Ready IOR IOR
AUROBINDO PHARMA
12
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Ondansetron HCl Tablet 4,8 mg CTD Ready IOR IOR
Pantoprazole sodium Tablet - DR 20,40mg CTD Ready IOR IOR
Paroxetine HCl Tablet 20,30mg CTD Ready IOR IOR
Pen V potassium Tablet 250, 800, 1000mg, 1.0 m.u, 1.5m.u CTD Ready IOR IOR
Perindopril Erbumine Tablet 2,4,8mg CTD Ready IOR IOR
Phenytoin Sodium Tablet EU: 50,100mg CTD Ready IOR IOR
Pioglitazone Tablet 15,30,45mg CTD Ready IOR IOR
Pramipexole Tablet 0.125, 0.25, 0.5, 1, 1.5 mg CTD Ready IOR IOR
Pravastatin Tablet 10, 20, 40mg CTD Ready IOR IOR
Quinapril HCl Tablet 5,10,20,40mg CTD Ready IOR IOR
Quinapril HCl + HTZ Tablet 10+12.5, 20+12.5, 20+25 mg CTD Ready IOR IOR
Ramipril Capsule 1.25,2.5,5,10mg: CTD Ready IOR IOR
Ramipril Tablet 1.25, 2.5, 5,10mg; CTD Ready IOR IOR
Ranitidine HCl Syrup 15mg/1ml CTD Ready IOR IOR
Repaglinide Tablet 0.5, 1, 2 mg CTD Ready IOR IOR
Ribavirin Capsule 200mg CTD Ready IOR IOR
Ribavirin Tablet 200, 400mg CTD Ready IOR IOR
Risedronate Tablet 5, 30, 35mg CTD Ready IOR IOR
Risedronate Sodium+Calcium carbonate
Tablet 35+500mg; CTD Ready IOR IOR
Risperidone Tablet 0.5,1,2,3,4,6mg, CTD Ready IOR IOR
Risperidone Solution - Oral 1mg/ml CTD Ready IOR IOR
Rizatriptan Tablet 5, 10mg CTD Ready IOR IOR
Rizatriptan Tablet - Dispersible (ODT) 5, 10mg CTD Ready IOR IOR
Ropinirole Tablet 0.25,0.5,1,2,5 mg CTD Ready IOR IOR
Rosuvastatin Ca Tablet 5, 10, 20, 40mg CTD Ready IOR IOR
Sertraline HCl Tablet 50,100mg CTD Ready IOR IOR
AUROBINDO PHARMA
13
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Sertraline HCl Tablet 50,100mg CTD Ready IOR IOR
Sertraline HCl Capsule 25,50,100mg CTD Ready IOR IOR
Simvastatin Tablet 5,10,20,30,40,60,80mg; CTD Ready IOR IOR
Sotalol Tablet 40, 80, 160mg CTD Ready IOR IOR
Sumatriptan Succinate Tablet 50,100 mg; CTD Ready IOR IOR
Tamsulosin HCl Capsule 0.4mg CTD Ready IOR IOR
Terbinafine Tablet 125, 250mg CTD Ready IOR IOR
Topiramate Tablet 25,50,100,200mg CTD Ready IOR IOR
Torsemide Tablet 5,10mg CTD Ready IOR IOR
Tramadol HCl Capsule 50 mg CTD Ready IOR IOR
Tramadol HCl + Acetaminophen Tablet 37.5+325 mg CTD Ready IOR IOR
Trandolapril Capsule 0.5,1,2, 4mg CTD Ready IOR IOR
Ursodiol Tablet 150, 250, 300, 400, 450, 500mg | CTD Ready IOR IOR
Ursodiol Capsule 150, 200, 250, 300mg CTD Ready IOR IOR
Valacyclovir Tablet 500,1000 mg; CTD Ready IOR IOR
Venlafaxine HCl Tablet 25,37.5,50,75mg CTD Ready IOR IOR
Venlafaxine HCl Capsule - XR 37.5, 75, 150mg CTD Ready IOR IOR
Zidovudine Capsule 100, 250mg CTD Ready IOR IOR
Zolpidem Tartrate Tablet 5,10mg CTD Ready IOR IOR
AUROBINDO PHARMA
14
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
COUNTRYPortugal
CITYCoimbra
COMPANY NAMEBluepharma
Bluepharma is a privately owned pharmaceutical company, based in Portugal. The main activities of the company include development, manufacturing and marketing of generic products for human use. Bluepharma has human resources and dedicated facilities allocated to R&D activities, covering formulation, development and validation of analytical methods, scale-up, manufacturing of pilot batches, stability studies and regulatory affairs. Our company is approved for the manufacturing and packaging of human investigational medicinal products. Starting in 2010 Bluepharma has the capacities to develop oncology products. The manufacturing site of the company exhibits a modern layout and is equipped with state of the art equipment for the manufacturing of solid dosage forms. We account for a significant track record of successful developments, as well as for innumerous partnerships with top players in the pharmaceutical industry worldwide, including USA.
Core Sales Territory: Global Regulated MarketsCore Operation: Sales and Marketing, Finished Dose Manufacture, DistributionContact Person: Mr. André Garnel Freitas; Head of Business Development
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Acarbose Tablet 25 mg, 50 mg, 100 mg CTD Ready Portugal PLG
Aripiprazole Tablet 5 mg, 10 mg, 15 mg, 20 mg, 30 mg CTD Ready N / A NRP
Atorvastatin Tablet - Film coated 10 mg, 20 mg, 40 mg, 80 mg CTD Ready Portugal IOR
Azithromycin Tablet - Film coated 500 mg CTD Ready Portugal PLG
Candesartan Tablet 2 mg, 4 mg, 8 mg, 16 mg, 32 mg CTD Ready Portugal PLG
Candesartan + HCTZ Tablet 8 mg + 12.5 mg, 16 mg + 12.5 mg CTD Ready Portugal PLG
Clarithromycin Tablet - Film coated 250 mg, 500 mg CTD Ready Portugal PLG
Clopidogrel Besylate Tablet 75 mg CTD Ready N / A IOR
Ibandronate / Ibandronic Acid Tablet - Film coated 50 mg, 150 mg CTD Ready N / A IOR
Irbesartan Tablet - Film coated 75 mg, 150 mg, 300 mg CTD Ready N / A DCP underway
Irbesartan + HCTZ Tablet - Film coated150 mg + 12.5 mg, 300 mg + 12.5 mg, 300 mg + 25 mg
CTD Ready N / A DCP underway
Levetiracetam Solution - Oral 100 mg/ml CTD Ready Portugal PLG
Levetiracetam Tablet - Film coated 250 mg, 500 mg, 750 mg, 1000 mg CTD Ready Portugal PLG
Losartan Tablet - Film coated 12.5 mg, 25 mg, 50 mg, 100 mg CTD Ready Portugal PLG
Losartan + HCTZ Tablet - Film coated 50 mg + 12.5 mg, 100 mg + 25 mg CTD Ready Portugal PLG
Nicorandil Tablet 10 mg, 20 mg CTD Ready Portugal PLG
Nimesulide Tablet 100 mg CTD Ready Portugal PLG
Pramipexole Tablet - Film coated 125 µg, 250 µg, 500 µg, 1000 µg, 1500 µg CTD Ready Portugal NRP
Propiverine Tablet - Film coated 5 mg, 15 mg CTD Ready Portugal PLG
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)15
COUNTRYIreland
CITYLoughrea
COMPANY NAMEChanelle
The Chanelle Group was established in 1983 as a distributor of animal health products and is now the largest veterinary pharma-ceutical manufacturer and distributor in Ireland. It diversified in 1980 into the development and manufacture of veterinary generic pharmaceutical products and is also a major player in the pet care market. A further diversification in 1995 with Chanelle Medical been established as a developer & manufacturer of medical generic products. Chanelle Medical are a one-stop-shop where we offer; formulation development, method development & validation, pilot batches, stability studies, monitoring of BE studies, compilation of dossier, registration of dossier, sale of dossier, manufacture and packing finish product. This company has approximately 900 generic product licenses (both Vet & Med) granted to date in 80 countries. The Group is privately owned, has a turnover of €60m, 220 employees with it’s head office in Loughrea, Co. Galway and offices in UK, France & Jordan. Core Sales Territory: Western EuropeCore Operation: Sales and Marketing, Finished Dose ManufactureContact Person: Mrs. Chanelle McCoy; Director of Medical Business
Molecule name DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Alkamed (Gaviscon) Solution - Oral 0.5% CTD Ready Ireland PLG
Amlodipine Capsule 5 mg, 10 mg CTD Ready Ireland PLG
Amorolfine Nail Lacquer 5% CTD Ready Ireland DCP underway
Atenolol Solution - Oral 25 mg / 5 ml CTD Ready Ireland PLG
Bisacodyl Tablet 5 mg CTD Ready Ireland PLG
Bisoprolol Tablet 1.25 mg, 2.5 mg, 3.75 mg, 5 mg, 7.5 mg, 10 mg CTD Ready Ireland PLG
Cefaclor Capsule 250 mg, 500 mg CTD Ready Ireland PLG
Cetirizine Solution - Oral 1 mg/ml CTD Ready Ireland PLG
Cetirizine Tablet 10 mg CTD Ready Ireland PLG
Citalopram Tablet 10 mg, 20 mg, 40 mg CTD Ready Ireland PLG
Clindamycin Capsule 75 mg, 150 mg, 300 mg CTD Ready Ireland PLG
Doxycycline Capsule 50 mg, 100 mg CTD Ready Ireland PLG
Escitalopram Solution - Oral 20 mg/ml CTD Ready N / ADCP slot booked (Dec 2011)
Exemestane Tablet 25 mg CTD Ready Ireland DCP underway
Fexofenadine Tablet 120 mg, 180 mg CTD Ready Ireland PLG
Frovatriptan Tablet 2.5 mg CTD In-Dev N / ADCP slot booked (Dec 2011)
Glibenclamide Tablet 1.25 mg, 2.5 mg, 5 mg CTD Ready Ireland PLG
Glucosamine Sulphate Tablet - Film coated 500 mg (3x daily), 750 mg (2x daily), 1000 mg (1x daily) CTD Ready Ireland PLG
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission. 16
Molecule name DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Lacidipine Tablet 4 mg, 6 mg CTD In-Dev N / A NRP
Macrogol (Movicol) Sachet 6.86g, 13.72g CTD Ready N / A DCP underway
Meloxicam Tablet 7.5 mg, 15 mg CTD Ready Ireland PLG
Memantine Solution - Oral 10 mg/ml CTD In-Dev N / A DCP slot booked
Metronidazole Tablet 200 mg, 400 mg CTD Ready Ireland PLG
Mirtazapine Tablet - Dispersible (ODT) 15 mg, 30 mg, 45 mg CTD Ready Ireland PLG
Naratriptan Tablet 2.5 mg CTD Ready N / A DCP underway
Olanzapine Tablet 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg CTD Ready Ireland PLG
Paroxetine Hemihydrate Tablet 20 mg, 30 mg CTD Ready Ireland PLG
Riluzole Tablet 50 mg CTD In-Dev N / ADCP slot booked (Febr 2012)
Risperidone Solution - Oral 1 mg/ml CTD Ready Ireland PLG
Roxithromycin Tablet 150 mg CTD Ready Ireland PLG
Sodium Bicarbonate Capsule 500 mg CTD Ready Ireland PLG
Sumatriptan Succinate Tablet 50 mg, 100 mg CTD Ready Ireland PLG
Zonisamide Capsule 25 mg, 50 mg, 100 mg CTD In-Dev N / A NRP
CHANELLE MEDICAL
54
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
COUNTRYIndia
CITYMaharashtra
COMPANY NAMEFamycare
Famy Care Ltd, was established in 1987 with a vision to become a key player in the Family Planning & Women’s Healthcare. Today, we are a leading manufacturer of Oral Contraceptive Pills, contraceptive injectables, Intrauterine Devices and Condoms in a short span of time. Famy Care has been very active in Regulated market such as US, EU and South Africa. We have filed more than 20 ANDAs with the USFDA in less than 18 months which highlights our technical competence and capabilities. In Semi-Regulated markets, we have attained a pan global leadership status within the contraceptive segment .We export to more than 60 countries in Asia, Latin America and Africa. We work closely with various leading international bodies like UNFPA, IPPF, PSI etc to bring high quality, afford-able contraceptives in the markets that need them the most.
Core Sales Territory: Global Non Regulated MarketsCore Operation: Finished Dose Manufacture, Sales and MarketingContact Person: Mr Ashutosh Dharmadhikari; Business Development
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Chlormadinone + EE Tablet 2mg+0.03mg eCTD In-Dev N / A DCP slot booked
Desogestrel Tablet 0.075mg eCTD In-Dev N / A DCP slot booked
Desogestrel + EE Tablet 0.15mg+0.03mg eCTD Ready India DCP underway
Desogestrel + EE Tablet 0.15mg+0.02mg eCTD Ready India DCP underway
Dienogest + EE Tablet 2mg+0.03mg eCTD In-Dev N / A DCP slot booked
Drospirenone + EE Tablet 3mg+0.02mg eCTD In-Dev N / A NRP
Drospirenone + EE Tablet 3mg+0.03mg eCTD In-Dev N / A NRP
Gestodene + EE Tablet 0.06mg+0.015mg eCTD In-Dev N / A DCP slot booked
Gestodene + EE Tablet 0.075mg+0.02mg eCTD In-Dev N / A DCP slot booked
Gestodene + EE Tablet 0.075mg+0.03mg eCTD In-Dev N / A DCP slot booked
Levonorgestrel Tablet 1.5 mg eCTD In-Dev N / A NRP
Levonorgestrel + EE Tablet 0.15mg+0.03mg eCTD Ready India PLG
Levonorgestrel + EE Tablet 0.10mg+0.02mg eCTD Ready India DCP underway
Medroxyprogesterone Acetate Injection 150mg/1ml eCTD In-Dev N / A NRP
Mifepristone Tablet 200 mg eCTD In-Dev N / A NRP
Norgestimate + EE Tablet 0.25mg+0.035mg eCTD Ready India DCP slot booked
18
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
COUNTRYSpain
CITYBarcelona
COMPANY NAMEFarmaprojects
Farmaprojects S.A. has 23 years of experience in development, registration and supply of generic drug products to third parties. Farmaprojects bases its out-licensing activities around the four key areas of: ensuring a top quality dossier, giving expert IP advice, regulatory affairs and registration support and pricing support throughout the product life cycle.Farmaprojects has also recently become an exclusive partner for commercialization through out-licensing agreements of all Polpharma products in European markets, thus significantly increasing its product portfolio and development pipeline. Our mission: Your success is what matters to us - An MAA dossier that exceeds the strictest standards of today’s pharmaceutical markets.
Core Sales Territory: Global Regulated MarketCore Operation: API Manufacture, API Manufacture, Finished Dose Manufacture, Finished Dose Manufacture, Sales and Market-ing, Sales and Marketing, DistributionContact Person: Tomasz Pawliszewski; International Business Development Manager
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Aciclovir Tablet 200mg – 400mg – 800mg eCTD Ready IOR
Alendronate/Alendronic Acid Tablet 70mg eCTD Ready IOR
Bicalutamide Tablet - Film coated 50mg - 150 mg eCTD Ready IOR
Bimatoprost Drops - Eye 0,3 mg/ml eCTD In-Dev N / A
Candesartan Tablet 4mg - 8mg - 16mg - 32mg eCTD Ready IOR
Candesartan + HCTZ Tablet 8mg/12,5mg – 16mg/12,5mg eCTD In-Dev N / A
Ciprofloxacin Tablet 250mg – 500mg eCTD Ready IOR
Citalopram Solution - Oral 40mg/ml eCTD Ready IOR
Citalopram Injection - Solution 20mg/0,5ml - 40mg/1ml eCTD Ready IOR
Citalopram Tablet - Film coated 10mg - 20mg - 30mg - 40 mg eCTD Ready IOR
Clarithromycin Powder - Infusion 500mg eCTD Ready IOR
Desloratadine Tablet - Film coated 5mg eCTD In-Dev N / ADCP Slot: February 2011
Desloratadine Solution - Oral 0,5mg/ml eCTD In-Dev N / ADCP Slot: February 2011
Dorzolamide Drops - Eye 20mg/ml eCTD Ready IOR
Dorzolamide + Timolol Drops - Eye 20mg+5mg/ml eCTD Ready IOR
Doxylamine Tablet 15mg - 25mg eCTD Ready IOR
Enalapril Tablet 5mg – 10mg – 20mg eCTD In-Dev N / A
Enalapril Tablet 5mg – 10mg – 20mg eCTD Ready IOR
19
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Enalapril + HCTZ Tablet 20mg/12,5mg eCTD Ready IOR
Eplerenone Tablet 25mg - 50mg eCTD Ready IOR
Escitalopram Tablet - Film coated 5mg - 10mg- 15mg - 20mg eCTD Ready IOR
Esomeprazole Powder - Infusion 40mg eCTD Ready IOR
Fenspiride Tablet 80mg eCTD Ready IOR
Gabapentin Capsule - Hard gel 100mg - 300mg - 400mg eCTD Ready IOR
Ibuprofen Suspension - Oral 100mg/ 5ml eCTD Ready IOR
Imatinib Tablet 100mg – 400mg eCTD In-Dev N / ADCP Slot: November 2011
Indapamide Tablet - SR 1,5mg eCTD Ready IOR
Irbesartan Tablet - Film coated 75mg – 150mg – 300mg eCTD Ready IOR
Irbesartan + HCTZ Tablet - Film coated 150mg/12,5mg - 300mg/12,5mg - 300mg/25mg eCTD Ready IOR
Levetiracetam Tablet 250mg - 500mg - 750mg - 1000mg eCTD Ready IOR
Levetiracetam Injection - Solution 100mg/ml eCTD Ready IOR
Levetiracetam Solution - Oral 100mg/ml eCTD Ready IOR
Levofloxacin Injection - Solution 250mg/50ml – 500mg/100ml eCTD Ready IOR
Levofloxacin Tablet - Film coated 250mg – 500mg eCTD Ready IOR
Linezolid Injection - Solution 2mg/ml eCTD In-Dev N / A
Losartan Tablet - Film coated 12,5mg - 25mg - 50mg – 100mg eCTD Ready IOR
Losartan + HCTZ Tablet - Film coated 50mg/12,5mg – 100mg/25mg eCTD Ready IOR
Meloxicam Injection - Solution 15mg/1,5ml eCTD Ready IOR
Memantine Tablet - Film coated 10mg – 20 mg eCTD In-Dev N / A
Memantine Drops - Oral 10mg/g eCTD In-Dev N / A
Metoprolol Succinate Tablet - SR 23,75mg - 47,5mg - 95mg - 190mg eCTD Ready IOR
Montelukast Sodium Tablet - Film coated 10mg eCTD Ready IOR
Montelukast Sodium Tablet - Chewable 4mg - 5mg eCTD Ready IOR
Montelukast Sodium Sachet 4mg eCTD In-Dev N / A DCP Slot: July 2011
FARMAPROJECTS
20
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Moxifloxacin Drops - Eye 15mg/3ml eCTD Ready IOR
Olanzapine Tablet 2,5mg - 5mg - 7,5mg - 10mg - 15mg - 20mg eCTD Ready IOR
Olanzapine Tablet - Dispersible (ODT) 5mg - 10mg - 15mg - 20mg eCTD Ready IOR
Olopatadine Drops - Eye 0.10% eCTD In-Dev N / A
Omeprazole Powder - Infusion 40mg eCTD Ready IOR
Ondansetron Injection - Solution 4mg/2ml - 8mg/4ml eCTD Ready IOR
Ondansetron Tablet - Dispersible (ODT) 4mg - 8mg eCTD Ready IOR
Opipramol HCl Tablet - Film coated 50mg eCTD Ready IOR
Orlistat Capsule 60mg - 120mg eCTD Ready IOR
Pantoprazol Injection - Lyophilisate for solution
40mg eCTD Ready IOR
Perindopril Tablet 4mg - 8mg eCTD Ready IOR
Piracetam Tablet - Film coated 800mg – 1200mg eCTD Ready IOR
Quetiapine Tablet - Film coated 25mg – 100mg – 150mg – 200mg 300mg eCTD Ready IOR
Rosuvastatin Tablet - Film coated 5mg – 10mg – 20mg – 40mg eCTD Ready IOR
Sildenafil Tablet 25mg – 50 mg – 100mg eCTD Ready IOR
Simethicone Drops - Oral 66mg/66ml eCTD Ready IOR
Simvastatin Tablet - Film coated 10mg – 20mg – 40mg – 80mg eCTD Ready IOR
Sumatriptan Tablet - Film coated 50mg, 100mg eCTD Ready IOR
Tianeptine Tablet - Film coated 12,5mg eCTD In-Dev N / ADCP Slot: March 2011
Topiramate Tablet 25mg – 50mg – 100mg – 200mg eCTD Ready IOR
Tramadol + Paracetamol Tablet - Film coated 37,5mg/ 325mg eCTD Ready IOR
Travoprost Drops - Eye 0,04mg/ml eCTD In-Dev N / A
Valsartan Tablet - Film coated 40mg – 80mg – 160mg – 320mg eCTD Ready IOR
Valsartan + HCTZ Tablet - Film coated 80/12,5mg - 160/12,5mg 160/25mg eCTD Ready IOR
Venlafaxine Tablet 25mg - 37,5mg - 50mg –75mg eCTD Ready IOR
Venlafaxine Capsule - PR 37,5mg - 75mg - 150mg eCTD Ready IOR
FARMAPROJECTS
21
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
COUNTRYJordan
CITYAmman
COMPANY NAMEHikma
Operations structured in three Business Units: Injectables, Generics and Branded Generics. Manufacturing operations established among 15 manufacturing sites in MENA, Western Europe and USA all 100% owned by Hikma.
Core Sales Territory: Middle East and North Africa, Regulated MarketCore Operation: API Manufacture, Finished Dose Manufacture, Sales and Marketing, DistributionContact Person: Mr. Eyad Hylooz; Business development and Allianze Manager
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Acarbose Tablet 50 mg CTD Ready IOR PLG
Acarbose Tablet 100 mg CTD Ready IOR PLG
Acetylsalicylic Acid Tablet 100 mg CTD Ready IOR PLG
Aciclovir Tablet 200 mg CTD Ready IOR PLG
Aciclovir Tablet 400 mg CTD Ready IOR PLG
Aciclovir Tablet 800 mg CTD Ready IOR PLG
Aciclovir Injection 250 mg CTD Ready IOR PLG
Alendronate / Alendronic Acid Tablet 5 mg CTD Ready IOR PLG
Alendronate / Alendronic Acid Tablet 10 mg CTD Ready IOR PLG
Alendronate / Alendronic Acid Tablet 70 mg CTD Ready IOR PLG
Allopurinol Tablet 100 mg CTD Ready IOR PLG
Allopurinol Tablet 300 mg CTD Ready IOR PLG
Alprazolam Tablet 0.25 mg CTD Ready IOR PLG
Alprazolam Tablet 0.5 mg CTD Ready IOR PLG
Alprazolam Tablet 1 mg CTD Ready IOR PLG
Alprazolam Tablet 2 mg CTD Ready IOR PLG
Aluminium Hydroxide + Magnesium Carbonate + Magnesium Hydroxide
Tablet 282 mg, 85 mg CTD Ready IOR PLG
Amikacin Injection 100 mg/ 2 ml CTD Ready IOR PLG
22
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Amikacin Injection 500 mg/ 2 ml CTD Ready IOR PLG
Amiodarone Injection 150 mg/ 3 ml CTD Ready IOR PLG
Amiodarone Injection 150 mg/ 3 ml ANDA Ready IOR PLG
Amlodipine Tablet 2.5 mg CTD Ready IOR PLG
Amlodipine Tablet 5 mg CTD Ready IOR PLG
Amlodipine Capsule 5 mg CTD Ready IOR PLG
Amlodipine Tablet 10 mg CTD Ready IOR PLG
Amlodipine + Valsartan Tablet 5 mg, 160 mg CTD Ready IOR PLG
Amoxicillin Capsule 250 mg CTD Ready IOR PLG
Amoxicillin Capsule 500 mg CTD Ready IOR PLG
Amoxicillin Tablet 1 g CTD Ready IOR PLG
Amoxicillin Syrup 125 mg/ 5 ml CTD Ready IOR PLG
Amoxicillin Syrup 250 mg/ 5 ml CTD Ready IOR PLG
Amoxicillin Drops 100 mg/ ml CTD Ready IOR PLG
Amoxicillin + Clavulanic Acid Tablet 875 mg, 125 mg CTD Ready IOR PLG
Amoxicillin + Clavulanic Acid Syrup 125 mg, 31.25 mg/ 5 ml CTD Ready IOR PLG
Amoxicillin + Clavulanic Acid Syrup 200 mg, 28.5 mg/ 5 ml CTD Ready IOR PLG
Amoxicillin + Clavulanic Acid Solution - Oral 600 mg, 42.9 mg/ 5 ml CTD Ready IOR PLG
Amoxicillin + Clavulanic Acid Injection 500 mg, 100 mg CTD Ready IOR PLG
Amoxicillin + Clavulanic Acid Injection 1000 mg, 200 mg CTD Ready IOR PLG
Amoxicillin + Clavulanic Acid Tablet 250 mg, 125 mg CTD Ready IOR PLG
Amoxicillin + Clavulanic Acid Tablet 500 mg, 125 mg CTD Ready IOR PLG
Amoxicillin + Clavulanic Acid Syrup 250 mg, 62.5 mg/ 5 ml CTD Ready IOR PLG
Amoxicillin + Clavulanic Acid Solution - Oral 400 mg, 57 mg/ 5 ml CTD Ready IOR PLG
Anusol - generic Suppository 59 mg, 24 mg, 49 mg, 296 mg CTD Ready IOR PLG
Anusol - generic Topical 2.25 g, 0.875 g, 1.875 g, 10.75 g CTD Ready IOR PLG
Aripiprazole Tablet 10 mg CTD Ready IOR PLG
HIKMA
23
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Aripiprazole Tablet 15 mg CTD Ready IOR PLG
Ascorbic Acid Capsule 250 mg CTD Ready IOR PLG
Ascorbic Acid Capsule 500 mg CTD Ready IOR PLG
Atenolol Tablet 50 mg CTD Ready IOR PLG
Atenolol Tablet 100 mg CTD Ready IOR PLG
Atenolol + Chlortalidone Tablet 100 mg CTD Ready IOR PLG
Atorvastatin Tablet 10 mg CTD Ready IOR PLG
Atorvastatin Tablet 20 mg CTD Ready IOR PLG
Atorvastatin Tablet 40 mg CTD Ready IOR PLG
Atorvastatin Tablet 80 mg CTD Ready IOR PLG
Atracurium Besylate Injection 25 mg/ 2.5 ml CTD Ready IOR PLG
Atracurium Besylate Injection 50 mg/ 5 ml CTD Ready IOR PLG
Atropine Injection 0.6 mg/ 1 ml CTD Ready IOR PLG
Azithromycin Capsule 250 mg CTD Ready IOR PLG
Azithromycin Capsule 500 mg CTD Ready IOR PLG
Azithromycin Tablet 500 mg CTD Ready IOR PLG
Azithromycin Syrup 100 mg/ 5 ml CTD Ready IOR PLG
Azithromycin Syrup 200 mg/ 5 ml CTD Ready IOR PLG
Azithromycin Solution - Oral 300 mg/ 7.5 ml CTD Ready IOR PLG
Azithromycin Injection 500 mg CTD Ready IOR PLG
Benzatropine mesylate Injection 1 mg/ ml ANDA Ready IOR PLG
Benzhexol Hydrochloride Tablet 2 mg CTD Ready IOR PLG
Benzhexol Hydrochloride Tablet 5 mg CTD Ready IOR PLG
Betamethasone + Gentamicin + Tolnaphtate + Clioquionol
Topical 0.5 mg, 1 mg, 10 mg, 10 mg/ g CTD Ready IOR PLG
Betamethasone + Neomycin Topical 1 mg, 5 mg/ g CTD Ready IOR PLG
Betamethasone Valerate Topical 1.25 mg/ g CTD Ready IOR PLG
HIKMA
24
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Bisacodyl Tablet 5 mg CTD Ready IOR PLG
Bisacodyl Suppository 5 mg CTD Ready IOR PLG
Bisacodyl Suppository 10 mg CTD Ready IOR PLG
Bismuth Subgallate, Bismuth oxide, Balsam peru, Zinc oxide
Suppository 59 mg, 24 mg, 49 mg, 296 mg CTD Ready IOR PLG
Bismuth Subgallate, Bismuth oxide, Balsam peru, Zinc oxide
Topical 2.25 g, 0.875 g, 1.875 g, 10.75 g CTD Ready IOR PLG
Bisoprolol + HCTZ Tablet 2.5 mg, 6.25 mg CTD Ready IOR PLG
Bisoprolol + HCTZ Tablet 5 mg, 6.25 mg CTD Ready IOR PLG
Bisoprolol + HCTZ Tablet 5 mg, 12.5 mg CTD Ready IOR PLG
Bisoprolol Fumarate Tablet 2.5 mg CTD Ready IOR PLG
Bisoprolol Fumarate Tablet 5 mg CTD Ready IOR PLG
Bisoprolol Fumarate Tablet 10 mg CTD Ready IOR PLG
Bromhexine Syrup 4 mg/ 5 ml CTD Ready IOR PLG
Bromocriptine Tablet 2.5 mg CTD Ready IOR PLG
Buflomedil HCl Tablet 150 mg CTD Ready IOR PLG
Bupivacaine Injection 0.25% (vials) CTD Ready IOR PLG
Bupivacaine Injection 0.50 % (vials) CTD Ready IOR PLG
Butorphanol tartrate Injection 1 mg/ ml ANDA Ready IOR PLG
Butorphanol tartrate Injection 2 mg/ ml ANDA Ready IOR PLG
Butorphanol tartrate Injection 20 mg/ 10 ml ANDA Ready IOR PLG
Calcipotriol Topical 0.05 mg/ g CTD Ready IOR PLG
Calcipotriol + Betametasone Dipropionate
Topical 0.05 mg, 0.5 mg/ g CTD Ready IOR PLG
Calcium Carbonate, Magnesium Hydroxide, Zinc Gluconate, Vitamin D3
Syrup375 mg (eq. to 150 mg Calcium), 180 mg (eq. to 75 mg magnesium), 21 mg (eq. to 3 mg zinc), 75 IU/ 5 ml
CTD Ready IOR PLG
Calcium Levulinate, Vitamin D3, Vitamin B12
Syrup 50 mg, 1000 IU, 10 mcg/ 5 ml CTD Ready IOR PLG
HIKMA
25
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Carboplatin Injection 50 mg/ 5 ml (Vials) CTD Ready IOR PLG
Carboplatin Injection 150 mg/ 15 ml CTD Ready IOR PLG
Carboplatin Injection 450 mg/ 45 ml CTD Ready IOR PLG
Carboplatin Injection 600 mg/ 60 ml CTD Ready IOR PLG
Carvedilol Tablet 3.125 mg CTD Ready IOR PLG
Carvedilol Tablet 6.25 mg CTD Ready IOR PLG
Carvedilol Tablet 12.5 mg CTD Ready IOR PLG
Carvedilol Tablet 25 mg CTD Ready IOR PLG
Cefaclor Syrup 125 mg/ 5 ml CTD Ready IOR PLG
Cefaclor Syrup 250 mg/ 5 ml CTD Ready IOR PLG
Cefaclor Capsule 250 mg CTD Ready IOR PLG
Cefaclor Capsule 500 mg CTD Ready IOR PLG
Cefadroxil Capsule 500 mg CTD Ready IOR PLG
Cefadroxil Syrup 250 mg/ 5 ml CTD Ready IOR PLG
Cefadroxil Solution - Oral 500 mg/ 5 ml CTD Ready IOR PLG
Cefalexin Capsule 250 mg CTD Ready IOR PLG
Cefalexin Capsule 500 mg CTD Ready IOR PLG
Cefalexin Syrup 125 mg/ 5 ml CTD Ready IOR PLG
Cefalexin Syrup 250 mg/ 5 ml CTD Ready IOR PLG
Cefazolin Injection 500 mg (vials) ANDA Ready IOR PLG
Cefazolin Injection 1 g (vials) CTD Ready IOR PLG
Cefazolin Injection 1 g (vials) ANDA Ready IOR PLG
Cefazolin Granules 2 g (vials) CTD Ready IOR PLG
Cefazolin Injection 10 g (vials) ANDA Ready IOR PLG
Cefixime Capsule 200 mg CTD Ready IOR PLG
Cefixime Capsule 400 mg CTD Ready IOR PLG
Cefixime Syrup 100 mg/ 5 ml CTD Ready IOR PLG
HIKMA
26
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Cefotaxime Injection 500 mg (vials) ANDA Ready IOR PLG
Cefotaxime Injection 1 g (vials) ANDA Ready IOR PLG
Cefotaxime Injection 2 g (vials) ANDA Ready IOR PLG
Cefotaxime Injection 10 g (vials) ANDA Ready IOR PLG
Cefoxitin Injection 1 g (vials) ANDA Ready IOR PLG
Cefradine Capsule 250 mg CTD Ready IOR PLG
Cefradine Capsule 500 mg CTD Ready IOR PLG
Ceftriaxone Injection 250 mg CTD Ready IOR PLG
Ceftriaxone Injection 250 mg ANDA Ready IOR PLG
Ceftriaxone Injection 500 mg CTD Ready IOR PLG
Ceftriaxone Injection 500 mg ANDA Ready IOR PLG
Ceftriaxone Injection 1 g CTD Ready IOR PLG
Ceftriaxone Injection 1 g ANDA Ready IOR PLG
Ceftriaxone Injection 2 g CTD Ready IOR PLG
Ceftriaxone Injection 2 g ANDA Ready IOR PLG
Cefuroxime Axetil Tablet 250 mg (Tablets) CTD Ready IOR PLG
Cefuroxime Axetil Tablet 500 mg (Tablets) CTD Ready IOR PLG
Cefuroxime Sodium Injection 750 mg CTD Ready IOR PLG
Cefuroxime Sodium Injection 750 mg ANDA Ready IOR PLG
Cefuroxime Sodium Injection 1.5 g CTD Ready IOR PLG
Cefuroxime Sodium Injection 1.5 g ANDA Ready IOR PLG
Cefuroxime Sodium Injection 7.5 g ANDA Ready IOR PLG
Cetirizine Dihydrochloride Tablet 10 mg CTD Ready IOR PLG
Chlordiazepoxide + Clidinium bromide Tablet 5 mg, 2.5 mg CTD Ready IOR PLG
Chlorphenamine Maleate + Caffeine Anhydrous + Paracetamol + Phenylephrine
Tablet 2 mg, 65 mg, 300 mg, 10 mg CTD Ready IOR PLG
HIKMA
27
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Chlorphenamine Maleate Syrup 2.5 mg/ 5 ml CTD Ready IOR PLG
Chlorphenamine Maleate Tablet 4 mg CTD Ready IOR PLG
Chlorphenamine Maleate Injection 10 mg/ 1 ml CTD Ready IOR PLG
Chlorzoxazone + Paracetamol Capsule 250 mg, 300 mg CTD Ready IOR PLG
Cilostazol Tablet 50 mg CTD Ready IOR PLG
Cilostazol Tablet 100 mg CTD Ready IOR PLG
Ciprofloxacin Tablet 250 mg CTD Ready IOR PLG
Ciprofloxacin Tablet 500 mg CTD Ready IOR PLG
Ciprofloxacin Tablet 750 mg CTD Ready IOR PLG
Ciprofloxacin Injection 2 mg/ ml CTD Ready IOR PLG
Ciprofloxacin Injection 2 mg/ ml ANDA Ready IOR PLG
Ciprofloxacin Injection 10 mg/ ml ANDA Ready IOR PLG
Citalopram Tablet 20 mg CTD Ready IOR PLG
Citalopram Tablet 40 mg CTD Ready IOR PLG
Clarithromycin Tablet 250 mg CTD Ready IOR PLG
Clarithromycin Tablet 500 mg CTD Ready IOR PLG
Clindamycin Phosphate Injection 300 mg/ 2 ml CTD In-Dev N / A IOR
Clindamycin Phosphate Injection 600 mg/ 4 ml CTD In-Dev N / A IOR
Clopidogrel Tablet 75 mg CTD Ready IOR PLG
Codeine phosphate + Chlorphenamine + Guaifenesin + Potassium Citrate + Sodium Benzoate + Liquid Extract of Liquorice
Syrup7.5 mg, 2.5 mg, 100 mg, 300 mg, 300 mg, 750 mg/ 10 ml
CTD Ready IOR PLG
Deferoxamine Mesylate Injection 500 mg (vials) CTD Ready IOR PLG
Desloratadine Syrup 0.5 mg/ 1 ml CTD Ready IOR PLG
Dexamethasone Sodium Phosphate Injection 4 mg/ ml CTD Ready IOR PLG
Dextromethorphan HBr Syrup 15 mg/ 5 ml CTD Ready IOR PLG
HIKMA
28
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Dextromethorphan HBr + Pseudoephedrine HCl + Chlorphenamine Maleate + Guaifenesin
Syrup 10 mg, 30 mg, 1.25 mg, 50 mg/ 5 ml CTD Ready IOR PLG
Diazepam Injection 10 mg/ 2 ml CTD Ready IOR PLG
Diclofenac Potassium Powder 50 mg CTD Ready IOR PLG
Diclofenac Potassium Tablet 50 mg CTD Ready IOR PLG
Diclofenac Sodium Tablet 25 mg (EC Tablets) CTD Ready IOR PLG
Diclofenac Sodium Suppository 25 mg CTD Ready IOR PLG
Diclofenac Sodium Suppository 50 mg CTD Ready IOR PLG
Diclofenac Sodium Tablet 50 mg (EC Tablets) CTD Ready IOR PLG
Diclofenac Sodium Tablet 75 mg (SR Tablets) CTD Ready IOR PLG
Diclofenac Sodium Suppository 100 mg CTD Ready IOR PLG
Diclofenac Sodium Capsule 100 mg CTD Ready IOR PLG
Diclofenac Sodium Tablet 100 mg (SR Tablets) CTD Ready IOR PLG
Diclofenac Sodium Tablet 150 mg (SR Tablets) CTD Ready IOR PLG
Diclofenac Sodium Suppository 12.5 mg CTD Ready IOR PLG
Diclofenac Sodium Topical 10 mg/ 1 g (Gel, Emulgel) CTD Ready IOR PLG
Diclofenac Sodium Topical 1 % (TGEL) CTD Ready IOR PLG
Diclofenac Sodium Injection 75 mg/ 3 ml CTD Ready IOR PLG
Dill seed oil, Sodium bicarbonate Syrup 2.3 mg, 52.5 mg/ 5 ml CTD Ready IOR PLG
Diosmin + Hesperidin Tablet 450 mg, 50 mg CTD Ready IOR PLG
Dipyridamole Tablet 75 mg CTD Ready IOR PLG
Doxazosin Tablet 1 mg CTD Ready IOR PLG
Doxazosin Tablet 4 mg CTD Ready IOR PLG
Doxycycline Hyclate Capsule 50 mg CTD Ready IOR PLG
Doxycycline Hyclate Capsule 100 mg CTD Ready IOR PLG
Enalapril Injection 1.25 mg/ ml ANDA Ready IOR PLG
HIKMA
29
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Ephedrine HCl, Chlorphenamine Maleate, Guaifenesin, Potassium Citrate, Sodium Benzoate, Liquid Extract of Liquorice
Syrup10 mg, 2.5 mg, 100 mg, 300 mg, 300 mg, 750 mg/ 10 ml
CTD Ready IOR PLG
Epinephrine Injection 1 mg/ ml ANDA Ready IOR PLG
Epirubicin HCl Injection 10 mg/ 5 ml CTD Ready IOR PLG
Epirubicin HCl Granules 50 mg/ 25 ml CTD Ready IOR PLG
Epirubicin HCl Injection 200 mg/ 100 ml CTD Ready IOR PLG
Erythromycin Syrup 125 mg/ 5 ml CTD Ready IOR PLG
Erythromycin Syrup 200 mg/ 5 ml CTD Ready IOR PLG
Erythromycin Solution - Oral 400 mg/ 5 ml CTD Ready IOR PLG
Erythromycin Tablet 250 mg CTD Ready IOR PLG
Erythromycin Tablet 500 mg CTD Ready IOR PLG
Escitalopram Tablet 5 mg (Tablets) CTD Ready IOR PLG
Escitalopram Tablet 10 mg (Tablets) CTD Ready IOR PLG
Escitalopram Tablet 20 mg (Tablets) CTD Ready IOR PLG
Esmolol Injection 2.5 mg/ 10 ml CTD Ready IOR PLG
Famotidine Tablet 10 mg CTD Ready IOR PLG
Famotidine Tablet 20 mg CTD Ready IOR PLG
Famotidine Tablet 40 mg CTD Ready IOR PLG
Fexofenadine HCl Tablet 120 mg CTD Ready IOR PLG
Fexofenadine HCl Tablet 180 mg CTD Ready IOR PLG
Finasteride Tablet 5 mg CTD Ready IOR PLG
Fluconazole Capsule 50 mg CTD Ready IOR PLG
Fluconazole Capsule 150 mg CTD Ready IOR PLG
Fluconazole Injection 2 mg/ ml CTD Ready IOR PLG
Fluconazole Injection 2 mg/ ml ANDA Ready IOR PLG
Flumazenil Injection 0.1 mg/ ml CTD Ready IOR PLG
HIKMA
30
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Flumazenil Injection 0.1 mg/ ml ANDA Ready IOR PLG
Fluoxetine Capsule 20 mg CTD Ready IOR PLG
Flutamide Capsule 250 mg (Capsules) CTD Ready IOR PLG
Folic Acid (Vitamin B9) Tablet 5 mg CTD Ready IOR PLG
Folic acid + Ferrous Sulphate Tablet 0.5 mg, 150 mg CTD Ready IOR PLG
Folic acid + Ferrous Sulphate + Zinc Oxide
Tablet 0.5 mg, 150 mg, 61.8 mg CTD Ready IOR PLG
Folinic Acid Injection 10 mg/ ml (Vials) CTD Ready IOR PLG
Fosphenytoin Sodium Injection 75 mg/ ml ANDA Ready IOR PLG
Furosemide Tablet 40 mg CTD Ready IOR PLG
Furosemide Injection 20 mg/ 2 ml CTD Ready IOR PLG
Fusidic Acid Topical 20 mg/ g CTD Ready IOR PLG
Fusidic Acid + Betamethasone Valerate Topical 20 mg, 1 mg/ g CTD Ready IOR PLG
Gabapentin Capsule 100 mg CTD Ready IOR PLG
Gabapentin Capsule 300 mg CTD Ready IOR PLG
Gabapentin Capsule 400 mg CTD Ready IOR PLG
Gemcitabine Injection 1 g (Vials) CTD Ready IOR PLG
Gemcitabine Injection 200 mg (Vials) CTD Ready IOR PLG
Gemfibrozil Tablet 600 mg CTD Ready IOR PLG
Gentamicin Sulphate Injection 10 mg/ ml (vials) CTD Ready IOR PLG
Gentamicin Sulphate Injection 40 mg/ ml (vials) CTD Ready IOR PLG
Glibenclamide Tablet 5 mg CTD Ready IOR PLG
Glimepiride Tablet 1 mg CTD Ready IOR PLG
Glimepiride Tablet 2 mg CTD Ready IOR PLG
Glimepiride Tablet 3 mg CTD Ready IOR PLG
Glimepiride Tablet 4 mg CTD Ready IOR PLG
Glimepiride Tablet 6 mg CTD Ready IOR PLG
Glimepiride Tablet 8 mg CTD Ready IOR PLG
HIKMA
31
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Granisetron Injection 1 mg/ 1 ml CTD Ready IOR PLG
Granisetron Injection 1 mg/ 1 ml ANDA Ready IOR PLG
Granisetron Injection 3 mg/ 3 ml CTD Ready IOR PLG
Guaifenesin Syrup 100 mg/ 5 ml CTD Ready IOR PLG
Guaifenesin + Dextromethorphan HBr + Diphenhydramine HCl + Ephedrine HCl
Syrup 50 mg, 6.25 mg, 5 mg, 7.5 mg/ 5 ml CTD Ready IOR PLG
Hexetidine Solution - Oral 0.1 % w/v CTD Ready IOR PLG
Hydrocortisone Acetate, Balsam peru, Zinc Oxide, Benzyl benzoate, Bismuth Oxide, Bismuth Subgallate
Suppository 10 mg, 49 mg, 296 mg, 33 mg, 24 mg, 59 mg CTD Ready IOR PLG
Hydrocortisone Acetate, Balsam peru, Zinc Oxide, Benzyl benzoate, Bismuth Oxide, Bismuth Subgallate
Topical 0.25 g, 1.875 g, 10.75 g, 1.25 g, 0.875 g, 2.25 g CTD Ready IOR PLG
Hydrocortisone Hemisuccinate Injection 100 mg CTD Ready IOR PLG
Hydroxychloroquine Tablet 200 mg CTD Ready IOR PLG
Hyoscine Butylbromide Tablet 10 mg CTD Ready IOR PLG
Hyoscine Butylbromide Syrup 5 mg/ 5 ml CTD Ready IOR PLG
Hyoscine Butylbromide Injection 20 mg/ 1 ml CTD Ready IOR PLG
Ibuprofen Syrup 100 mg/ 5 ml CTD Ready IOR PLG
Ibuprofen Tablet 400 mg CTD Ready IOR PLG
Ibuprofen Tablet 600 mg CTD Ready IOR PLG
Ibuprofen Suppository 200 mg CTD Ready IOR PLG
Ibuprofen Tablet 200 mg CTD Ready IOR PLG
Ibuprofen + Paracetamol Syrup 100 mg, 125 mg/ 5 ml CTD Ready IOR PLG
Imatinib Mesilate Tablet 100 mg (Tablets) CTD Ready IOR PLG
Imatinib Mesilate Tablet 400 mg (Tablets) CTD Ready IOR PLG
Indometacin Capsule 25 mg CTD Ready IOR PLG
Irinotecan Injection 40 mg/ 2 ml CTD Ready IOR PLG
HIKMA
32
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Irinotecan Injection 100 mg/ 5 ml CTD Ready IOR PLG
Isoconazole Nitrate Topical 10 mg/ g CTD Ready IOR PLG
Isoconazole Nitrate + Diflucortolone Valerate
Topical 10 mg, 1 mg/ g CTD Ready IOR PLG
Itopride HCl Tablet 50 mg CTD Ready IOR PLG
Itraconazole Capsule 100 mg CTD Ready IOR PLG
Ketamine Injection 50 mg/ ml (vials) CTD Ready IOR PLG
Ketotifen Tablet 1 mg CTD Ready IOR PLG
Ketotifen Syrup 1 mg/ 5 ml CTD Ready IOR PLG
Lamotrigine Tablet 25 mg CTD Ready IOR PLG
Lamotrigine Tablet 50 mg CTD Ready IOR PLG
Lamotrigine Tablet 100 mg CTD Ready IOR PLG
Leflunomide Tablet 10 mg CTD Ready IOR PLG
Leflunomide Tablet 20 mg CTD Ready IOR PLG
Leflunomide Tablet 100 mg CTD Ready IOR PLG
Levetiracetam Syrup 100 mg/ 1 ml CTD Ready IOR PLG
Levetiracetam Tablet 250 mg CTD Ready IOR PLG
Levetiracetam Tablet 500 mg CTD Ready IOR PLG
Levetiracetam Tablet 750 mg CTD Ready IOR PLG
Levofloxacin Tablet 500 mg CTD Ready IOR PLG
Levofloxacin Tablet 750 mg CTD Ready IOR PLG
Levofloxacin Injection 5 mg/ ml (vials) CTD Ready IOR PLG
Levofloxacin Injection 5 mg/ ml (bags) CTD Ready IOR PLG
Lincomycin Injection 300 mg/ ml (vials) CTD Ready IOR PLG
Lisinopril Tablet 5 mg CTD Ready IOR PLG
Lisinopril Tablet 10 mg CTD Ready IOR PLG
Lisinopril Tablet 20 mg CTD Ready IOR PLG
HIKMA
33
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Lisinopril Tablet 40 mg CTD Ready IOR PLG
Lomefloxacin hydrochloride Tablet 400 mg CTD Ready IOR PLG
Loratadine Tablet 10 mg CTD Ready IOR PLG
Loratadine Syrup 5 mg/ 5 ml CTD Ready IOR PLG
Losartan Potassium Tablet 25 mg CTD Ready IOR PLG
Losartan Potassium Tablet 50 mg CTD Ready IOR PLG
Losartan Potassium Tablet 100 mg CTD Ready IOR PLG
Losartan Potassium + HCTZ Tablet 50 mg, 12.5 mg CTD Ready IOR PLG
Losartan Potassium + HCTZ Tablet 100 mg, 25 mg CTD Ready IOR PLG
Mebeverine HCl Tablet 135 mg CTD Ready IOR PLG
Mefenamic Acid Capsule 250 mg CTD Ready IOR PLG
Mefenamic Acid Tablet 250 mg CTD Ready IOR PLG
Mefenamic Acid Tablet 500 mg CTD Ready IOR PLG
Mefenamic Acid Syrup 50 mg/ 5 ml CTD Ready IOR PLG
Meloxicam Capsule 7.5 mg CTD Ready IOR PLG
Meloxicam Capsule 15 mg CTD Ready IOR PLG
Metformin HCl Tablet 500 mg CTD Ready IOR PLG
Metformin HCl Tablet 850 mg CTD Ready IOR PLG
Methylprednisolone Injection 40 mg CTD Ready IOR PLG
Metoclopramide HCl Injection 10 mg/ 2 ml CTD Ready IOR PLG
Metoprolol Tartrate Injection 5 mg/ 5 ml ANDA Ready IOR PLG
Metronidazole Syrup 125 mg/ 5 ml CTD Ready IOR PLG
Metronidazole Syrup 200 mg/ 5 ml CTD Ready IOR PLG
Metronidazole Tablet 250 mg CTD Ready IOR PLG
Metronidazole Tablet 500 mg CTD Ready IOR PLG
Metronidazole + Diloxanide furoate Tablet 200 mg, 250 mg CTD Ready IOR PLG
Metronidazole + Spiramycin Tablet 125 mg, 750.000 IU CTD Ready IOR PLG
HIKMA
34
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Midazolam Injection 1 mg/ ml (Ampoules) CTD Ready IOR PLG
Midazolam Injection 5 mg/ ml (Ampoules) CTD Ready IOR PLG
Milrinone Injection 1 mg/ ml CTD Ready IOR PLG
Milrinone Injection 1 mg/ ml ANDA Ready IOR PLG
Milrinone Injection 2 mg/ ml ANDA Ready IOR PLG
Montelukast Tablet 5 mg CTD Ready IOR PLG
Montelukast Tablet 10 mg CTD Ready IOR PLG
Multivitamins Syrup Combination of 9 vitamins CTD Ready IOR PLG
Multivitamins Tablet Combination of 12 vitamins CTD Ready IOR PLG
Naftidrofuryl Oxalate Capsule 200 mg CTD Ready IOR PLG
Naloxone HCl Injection 0.02 mg (Ampoules) CTD Ready IOR PLG
Naloxone HCl Injection 0.4 mg (Ampoules) CTD Ready IOR PLG
Naproxen Tablet 250 mg CTD Ready IOR PLG
Naproxen Suppository 500 mg CTD Ready IOR PLG
Naproxen Tablet 500 mg CTD Ready IOR PLG
Naproxen Syrup 125 mg/ 5 ml CTD Ready IOR PLG
Nebivolol Tablet 5 mg CTD Ready IOR PLG
Nicorandil Tablet 10 mg CTD Ready IOR PLG
Nicorandil Tablet 20 mg CTD Ready IOR PLG
Nifuroxazide Capsule 200 mg CTD Ready IOR PLG
Nifuroxazide Syrup 220 mg/ 5 ml CTD Ready IOR PLG
Nimesulide Tablet 100 mg CTD Ready IOR PLG
Nimesulide Suppository 200 mg CTD Ready IOR PLG
Norethisterone Tablet 5 mg CTD Ready IOR PLG
Norfloxacin + Tinidazole Tablet 400 mg, 600 mg CTD Ready IOR PLG
Olanzapine Tablet 5 mg CTD Ready IOR PLG
Ondansetron Injection 32 mg/ 50 ml (Bags) CTD Ready IOR PLG
HIKMA
35
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Ondansetron Tablet 4 mg (Tablets) CTD Ready IOR PLG
Ondansetron Tablet 8 mg (Tablets) CTD Ready IOR PLG
Ondansetron Injection 4 mg/ 2 ml CTD Ready IOR PLG
Ondansetron Injection 4 mg/ 2 ml ANDA Ready IOR PLG
Ondansetron Injection 8 mg/ 4 ml CTD Ready IOR PLG
Orlistat Capsule 120 mg CTD Ready IOR PLG
Ornidazole Tablet 500 mg CTD Ready IOR PLG
Oxomemazine + Sodium Benzoate + Guaifenesin + Paracetamol
Syrup 1.65 mg, 33.3 mg, 33.3 mg, 33.3 mg/ 5 ml CTD Ready IOR PLG
Pamidronate / Pamidronic Acid Injection 15 mg/ 5 ml CTD Ready IOR PLG
Pamidronate / Pamidronic Acid Injection 30 mg/ 10 ml CTD Ready IOR PLG
Pamidronate / Pamidronic Acid Injection 60 mg/ 10 ml CTD Ready IOR PLG
Pamidronate / Pamidronic Acid Injection 90 mg/ 10 ml CTD Ready IOR PLG
Pancuronium Bromide Injection 2 mg/ ml (Ampoules) CTD Ready IOR PLG
Paracetamol Syrup 120 mg/ 5 ml CTD Ready IOR PLG
Paracetamol Syrup 125 mg/ 5 ml CTD Ready IOR PLG
Paracetamol Syrup 250 mg/ 5 ml CTD Ready IOR PLG
Paracetamol Tablet 500 mg CTD Ready IOR PLG
Paracetamol Tablet 500 mg CTD Ready IOR PLG
Paracetamol Suppository 250 mg CTD Ready IOR PLG
Paracetamol Suppository 125 mg CTD Ready IOR PLG
Paracetamol Suppository 120 mg CTD Ready IOR PLG
Paracetamol Suppository 100 mg CTD Ready IOR PLG
Paracetamol Suppository 200 mg CTD Ready IOR PLG
Paracetamol Suppository 350 mg CTD Ready IOR PLG
Paracetamol Suppository 320 mg CTD Ready IOR PLG
Paracetamol Suppository 650 mg CTD Ready IOR PLG
HIKMA
36
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Paracetamol Drops 100 mg/ ml CTD Ready IOR PLG
Paracetamol Injection 1 g/ 100 ml (Vials) CTD Ready IOR PLG
Paracetamol + Caffeine Tablet 500 mg, 65 mg CTD Ready IOR PLG
Paracetamol + Codeine Tablet 500 mg, 10 mg CTD Ready IOR PLG
Paracetamol + DL - Methionine Tablet 500 mg, 100 ml CTD Ready IOR PLG
Paracetamol + Phenobarbital Suppository 125 mg, 10 mg CTD Ready IOR PLG
Paracetamol + Phenobarbital Suppository 250 mg, 20 mg CTD Ready IOR PLG
Paracetamol + Pseudoephedrine HCl Tablet 500 mg, 30 mg CTD Ready IOR PLG
Paracetamol + Pseudoephedrine HCl + Chlorpheniramine maleate
Tablet 500 mg, 30 mg, 2 mg CTD Ready IOR PLG
Paracetamol + Pseudoephedrine HCl + Chlorpheniramine maleate
Tablet 500 mg, 30 mg, 2 mg CTD Ready IOR PLG
Paracetamol + Pseudoephedrine HCl + Chlorpheniramine maleate
Syrup 160 mg, 15 mg, 1 mg/ 5 ml CTD Ready IOR PLG
Phenobarbital Tablet 15 mg CTD Ready IOR PLG
Phenobarbital Tablet 30 mg CTD Ready IOR PLG
Phenobarbital Tablet 60 mg CTD Ready IOR PLG
Phenytoin Injection 50 mg/ ml CTD Ready IOR PLG
Phenytoin Injection 50 mg/ ml ANDA Ready IOR PLG
Piroxicam Injection 20 mg/ ml CTD Ready IOR PLG
Pizotifen Syrup 0.5 mg/ 5 ml CTD Ready IOR PLG
Prednisolone Tablet 5 mg CTD Ready IOR PLG
Prednisolone Tablet 25 mg CTD Ready IOR PLG
Prednisolone Syrup 5 mg CTD Ready IOR PLG
Prednisolone Syrup 15 mg CTD Ready IOR PLG
Pregabalin Capsule 75 mg CTD Ready IOR PLG
Pregabalin Capsule 150 mg CTD Ready IOR PLG
Progesterone Injection 50 mg/ ml ANDA Ready IOR PLG
HIKMA
37
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Promethazine Injection 25 mg/ ml ANDA Ready IOR PLG
Promethazine Injection 50 mg/ ml CTD Ready IOR PLG
Promethazine Injection 50 mg/ ml ANDA Ready IOR PLG
Propranolol Tablet 10 mg CTD Ready IOR PLG
Propranolol Tablet 40 mg CTD Ready IOR PLG
Propranolol Tablet 80 mg CTD Ready IOR PLG
Propranolol Injection 1 mg/ ml ANDA Ready IOR PLG
Ranitidine Tablet 75 mg CTD Ready IOR PLG
Ranitidine Tablet 150 mg CTD Ready IOR PLG
Ranitidine Tablet 300 mg CTD Ready IOR PLG
Ranitidine Injection 50 mg/ 2 ml CTD Ready IOR PLG
Ribavirin Capsule 200 mg CTD Ready IOR PLG
Ribavirin Capsule 400 mg CTD Ready IOR PLG
Risedronate Tablet 35 mg CTD Ready IOR PLG
Risedronate Sodium+Calcium carbonate Tablet 35 mg, 1250 mg CTD Ready IOR PLG
Risperidone Tablet 1 mg CTD Ready IOR PLG
Risperidone Tablet 2 mg CTD Ready IOR PLG
Risperidone Tablet 4 mg CTD Ready IOR PLG
Rivastigmine tartrate Capsule 1.5 mg CTD Ready IOR PLG
Rivastigmine tartrate Capsule 3 mg CTD Ready IOR PLG
Rivastigmine tartrate Capsule 4.5 mg CTD Ready IOR PLG
Rivastigmine tartrate Capsule 6 mg CTD Ready IOR PLG
Rosuvastatin Ca Tablet 10 mg CTD Ready IOR PLG
Rosuvastatin Ca Tablet 20 mg CTD Ready IOR PLG
Salbutamol Tablet 2 mg CTD Ready IOR PLG
Salbutamol Syrup 2 mg/ 5 ml CTD Ready IOR PLG
Sennosides Tablet 7.5 mg CTD Ready IOR PLG
HIKMA
38
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Sertraline Tablet 50 mg CTD Ready IOR PLG
Sertraline Tablet 100 mg CTD Ready IOR PLG
Sildenafil Tablet 50 mg CTD Ready IOR PLG
Simvastatin Tablet 10 mg CTD Ready IOR PLG
Simvastatin Tablet 20 mg CTD Ready IOR PLG
Simvastatin Tablet 40 mg CTD Ready IOR PLG
Simvastatin + Ezetimibe Tablet 20 mg, 10 mg CTD Ready IOR PLG
Simvastatin + Ezetimibe Tablet 40 mg, 10 mg CTD Ready IOR PLG
Sitagliptin Tablet 50 mg CTD Ready IOR PLG
Sitagliptin Tablet 100 mg CTD Ready IOR PLG
Sitagliptin + Metformin Tablet 50 mg, 1 g CTD Ready IOR PLG
Sodium Bicarbonate Capsule 500 mg CTD Ready IOR PLG
Sodium Fusidate Topical 20 mg/ g CTD Ready IOR PLG
Sodium Iron Edetate Syrup 15 mg Iron/ 5 ml CTD Ready IOR PLG
Sodium Valproate Injection 100 mg/ ml ANDA Ready IOR PLG
Somatostatin Injection 1 mg + 2 ml, 3 mg + 2 ml CTD Ready IOR PLG
Sufentanil (citrate) Injection 10 mcg/ 2 ml CTD Ready IOR PLG
Sufentanil (citrate) Injection 50 mcg/ 5 ml CTD Ready IOR PLG
Sufentanil (citrate) Injection 250 mcg/ 5 ml CTD Ready IOR PLG
Sufentanil (citrate) Injection 1000 mcg/ 20 ml CTD Ready IOR PLG
Sulfamethoxazole + Trimethoprim Syrup 200 mg, 40 mg/ 5 ml CTD Ready IOR PLG
Sulfamethoxazole + Trimethoprim Tablet 400 mg, 80 mg CTD Ready IOR PLG
Sulfamethoxazole + Trimethoprim Tablet 800 mg, 160 mg CTD Ready IOR PLG
Sumatriptan Succinate Tablet 50 mg CTD Ready IOR PLG
Sumatriptan Succinate Capsule 100 mg CTD Ready IOR PLG
Teicoplanin Injection 200 mg (vials) CTD Ready IOR PLG
Teicoplanin Injection 400 mg (vials) CTD Ready IOR PLG
HIKMA
39
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Terbinafine HCl Topical 10 mg/ g CTD Ready IOR PLG
Terbutaline Sulphate Injection 1 mg/ ml ANDA Ready IOR PLG
Thiamine HCl, Pyridoxine HCl, Riboflavin 5-phosphate Sodium, Nictotinamide, Ascorbic Acid, Sodium D-panthothenate
Syrup1.67 mg, 1.00 mg, 1.41 mg, 6.67 mg, 33.33 mg, 1.67 mg/ 5 ml
CTD Ready IOR PLG
Tioconazole Topical 10 mg/ g CTD Ready IOR PLG
Tizanidine HCl Tablet 4 mg CTD Ready IOR PLG
Tramadol HCl Capsule 50 mg CTD Ready IOR PLG
Tramadol HCl Tablet 200 mg CTD Ready IOR PLG
Tramadol HCl Injection 100 mg/ 2 ml CTD Ready IOR PLG
Triamcinolone Acetonide + Neomycin + Gramicidin + Nystatin
Topical 1 mg, 2.5 mg, 0.25 mg, 100 000 IU/ g CTD Ready IOR PLG
Tribenoside + Lidocaine Topical 5 mg, 2 g CTD Ready IOR PLG
Triprolidine + Pseudoephedrine HCl Syrup 1.25 mg, 30 mg/ 5 ml CTD Ready IOR PLG
Triprolidine + Pseudoephedrine HCl Tablet 2.5 mg, 60 mg CTD Ready IOR PLG
Triprolidine + Pseudoephedrine HCl + Dextromethorphan HBr
Syrup 1.25 mg, 30 mg, 10 mg/ 5 ml CTD Ready IOR PLG
Triprolidine + Pseudoephedrine HCl + Guaifenesin
Syrup 1.25 mg, 30 mg, 100 mg/ 5 ml CTD Ready IOR PLG
Triprolidine + Pseudoephedrine HCl + Paracetamol
Syrup 1.25 mg, 25 mg, 125 mg/ 5 ml CTD Ready IOR PLG
Triprolidine + Pseudoephedrine HCl + Paracetamol
Tablet 2.5 mg, 50 mg, 300 mg CTD Ready IOR PLG
Trospium Tablet 20 mg CTD Ready IOR PLG
Valacyclovir Tablet 1 g CTD Ready IOR PLG
Vancomycin HCl Injection 500 mg CTD Ready IOR PLG
Vancomycin HCl Injection 1000 mg CTD Ready IOR PLG
Vecuronium Bromide Injection 4 mg (Vials) CTD Ready IOR PLG
Vecuronium Bromide Injection 10 mg (Vials) CTD Ready IOR PLG
HIKMA
40
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
COMPANY NAMELogenex
COUNTRYGermany
CITYHamburg
LOGENEX Pharm GmbH offers sophisticated services and products for pharmaceutical companies. The company’s main business is the development of registration dossiers for generic drugs and worldwide licensing - with a special focus on oncology. We work closely with external experts in the field of drug development, API sourcing and Regulatory Affairs. This guarantees high quality results at competitive conditions for our Customers.
Core Sales Territory: Global Regulated MarketsCore Operation: Distribution, Finished Dose Manufacture, API ManufactureContact Person: Mr. Franz Rieger; Area Manager
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Topotecan Injection - Powder 1 mg, 4 mg CTD Ready Germany DCP underway
Zoledronic Acid Injection - Solution 4 mg / 5 ml CTD In-Dev N / ADCP slot booked (Aug 2011)
Alprazolam Tablet 0.5 mg IOR Ready Brazil Approved
Ambroxol Solution - Oral 3 mg/ml, 6 mg/ml IOR Ready Brazil Approved
41
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
COUNTRYUnited Kingdom
CITYKnutsford
COMPANY NAMELupin
Established in 1968 in India, Lupin’s vision is to be an innovation led transnational pharmaceutical company. Lupin is amongst the top 5 Indian pharmaceutical companies with world class EU GMP and USFDA approved manufacturing facilities. Lupin aims to be the partner of choice for economic and high quality pharmaceutical development and manufacturing. Offers: out-licensing and supply arrangements for its generic products/dossiers (CTD format), supply of APIs, generic dossier co-development and contract research & development.A drive for excellence through technology and research has earned Lupin a position in the top league of pharmaceutical companies from India. Lupin has become a global leader in the anti-TB segment and one of the world’s largest integrated manufacturers of cephalosporins, having sterile injectable, tablet, capsule and suspensions for reconstitution forms available. Lupin also leads in the manufacture of cardiovascular drugs, has significant fermentation capabilities producing drugs from the Statin class; and a range of developments spanning Sartans and Prazoles. Lupin’s Innovation Cell is focused on the development of drug delivery systems including taste-masking, chewable, tablet to liquid, invasive to noninvasive, oral controlled release and others.Core Sales Territory: Global Regulated MarketsCore Operation: Distribution, Sales and Marketing, Finished Dose Manufacture, API ManufactureContact Person: Mr. Andrew Macaulay; Vice President (BD)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Aspirin + Dipyridamole Capsule - XR 25 + 200mg eCTD In-Dev N / A IOR
Atorvastatin Tablet 10 mg, 20 mg, 40 mg, 80 mg eCTD In-Dev N / A IOR
Bimatoprost Drops - Eye 0.03% eCTD In-Dev N / A IOR
Bimatoprost + Timolol Drops - Eye 0.03% + 0.5% eCTD In-Dev N / A IOR
Brimonidine Drops - Eye 0.2% eCTD In-Dev N / A IOR
Brimonidine + Timolol Drops - Eye 0.2% + 0.5% eCTD In-Dev N / A IOR
Brinzolamide Drops - Eye 1% eCTD In-Dev N / A IOR
Candesartan Tablet 2 mg, 4 mg, 8 mg, 16 mg, 32 mg eCTD In-Dev N / A IOR
Candesartan + HCTZ Tablet8 mg + 12.5 mg, 16 mg + 12.5 mg, 32 mg + 12.5 mg, 32 mg + 25 mg
eCTD In-Dev N / A IOR
Cefixime Suspension 100 mg/5ml CTD Ready IOR DCP underway
Cefixime Tablet 200, 400mg CTD Ready IOR DCP underway
Cefotaxime Injection - Solution 500 mg, 1000 mg, 2000 mg NTA Ready UK IOR
Cefpodoxime Proxetil Suspension 40 mg / 5ml CTD Ready France DCP underway
Cefpodoxime Proxetil Tablet 100 mg, 200 mg CTD Ready France DCP underway
Ceftriaxone Injection - Solution 250 mg, 500 mg, 1000 mg, 2000 mg NTA Ready UK IOR
Cephalexin Capsule 250 mg, 500 mg eCTD Ready IOR DCP underway
Chlormadinone + EE Tablet 2 mg + 0.03 mg eCTD In-Dev N / A IOR
42
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Clarithromycin Tablet - XR 500 mg eCTD In-Dev N / A IOR
Desloratadine Tablet 5 mg CTD Ready IOR IOR
Desogestrel Tablet 0.075 mg eCTD In-Dev N / A IOR
Desogestrel + EE Tablet 0.15 mg + 0.02 mg eCTD In-Dev N / A IOR
Desogestrel + EE Tablet 0.15 mg + 0.03 mg eCTD In-Dev N / A IOR
Diacerein Capsule 50 mg CTD Ready IOR IOR
Dienogest + EE Tablet 2 mg + 0.03mg eCTD In-Dev N / A IOR
Dienogest + Estradiol Valerate Tablet 2 mg + 1 mg, 2 mg + 2 mg eCTD In-Dev N / A IOR
Dienogest + Estradiol Valerate Tablet 0/3 + 2/2 + 3/2 + 0/1mg eCTD In-Dev N / A IOR
Dorzolamide Drops - Eye 2% eCTD In-Dev N / A IOR
Dorzolamide + Timolol Drops - Eye 2%/0.5% eCTD In-Dev N / A IOR
Drospirenone + EE Tablet 3 mg + 0.03 mg eCTD In-Dev N / A IOR
Drospirenone + EE Tablet 3 mg + 0.02 mg eCTD In-Dev N / A IOR
Duloxetine Capsule 20 mg, 30 mg, 40 mg, 60 mg eCTD In-Dev N / A IOR
Escitalopram Tablet 5 mg, 10 mg, 15 mg, 20 mg CTD Ready IOR IOR
Esomeprazole Tablet 20 mg, 40 mg eCTD In-Dev N / A IOR
Flupirtine Capsule 100 mg eCTD In-Dev N / A IOR
Flupirtine Tablet - SR 400 mg eCTD In-Dev N / A IOR
Gestodene + EE Tablet 0.075/0.02mg eCTD In-Dev N / A IOR
Gestodene + EE Tablet 0.075/0.03mg eCTD In-Dev N / A IOR
Gestodene + EE Tablet 0.06/0.015mg eCTD In-Dev N / A IOR
Gliclazide Tablet - SR 30 mg eCTD In-Dev N / A IOR
Irbesartan Tablet 75 mg, 150 mg, 300 mg eCTD In-Dev N / A IOR
Irbesartan + HCTZ Tablet150 mg + 12.5 mg, 300 mg + 12.5 mg, 300 mg + 25 mg
eCTD In-Dev N / A IOR
Ketoprofen Tablet - XR 150 mg eCTD In-Dev N / A IOR
Lamivudine + Zidovudine Tablet 150 mg + 300 mg eCTD In-Dev N / A IOR
LUPIN
43
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Lansoprazole Capsule 15 mg, 30 mg eCTD In-Dev N / A IOR
Lansoprazole Tablet - Dispersible (ODT) 15 mg, 30 mg eCTD In-Dev N / A IOR
Latanoprost Drops - Eye 50 µg/ml (2.5 ml) eCTD In-Dev N / A IOR
Latanoprost + Timolol Drops - Eye 0.005% + 0.5% eCTD In-Dev N / A IOR
Levetiracetam Tablet 250 mg, 500 mg, 750 mg, 1000 mg CTD Ready IOR DCP underway
Levonorgestrel Tablet 1.5 mg eCTD In-Dev N / A IOR
Levonorgestrel + EE Tablet 0.15 mg + 0.03 mg eCTD In-Dev N / A IOR
Levonorgestrel + EE Tablet 0.1 mg + 0.2 mg eCTD In-Dev N / A IOR
Levonorgestrel + EE Tablet 0.125 mg + 0.03 mg eCTD In-Dev N / A IOR
Levonorgestrel + EE Tablet0.05 mg + 0.03 mg, 0.075 mg + 0.04 mg, 0.125 mg + 0.03 mg
eCTD In-Dev N / A IOR
Lisinopril Tablet 2.5 mg, 5 mg, 10 mg, 20 mg CTD Ready France MRP underway: UK
Lisinopril + HCTZ Tablet 10 mg + 12.5 mg, 20 mg + 12.5 mg CTD Ready UK MRP underway: UK
Losartan Tablet 12.5, 25, 50, 100mg CTD Ready France MRP underway: UK
Losartan + HCTZ Tablet50 mg + 12.5 mg, 100 mg + 12.5 mg, 100 mg + 25 mg
CTD Ready France MRP underway: UK
Memantine Tablet 5 mg, 10 mg, 15 mg, 20 mg eCTD Ready IOR IOR
Memantine Tablet 5 mg, 10 mg, 15 mg, 20 mg ANDA Ready IOR PLG
Norgestimate + EE Tablet 0.25 mg + 0.35 mg eCTD In-Dev N / A IOR
Omeprazole Capsule 10, 20, 40mg eCTD In-Dev N / A IOR
Pantoprazol Tablet 20 mg, 40 mg CTD Ready IOR DCP underway
Perindopril Tablet 2 mg, 4 mg, 8 mg CTD Ready France MRP underway: UK
Perindopril + Indapamide Tablet 2 mg + 0.625 mg, 4 mg + 1.25 mg CTD Ready IOR PLG
Pregabalin Capsule25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, 300 mg
eCTD In-Dev N / A IOR
Quetiapine Tablet 25mg, 100mg, 150mg, 200mg, 300mg eCTD In-Dev N / A IOR
Quetiapine Tablet - SR 50 mg, 200 mg, 300 mg, 400 mg eCTD In-Dev N / A IOR
LUPIN
44
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Quinapril Tablet 5 mg, 10 mg, 20 mg, 40 mg CTD Ready UK MRP underway: UK
Rabeprazole Tablet 10 mg, 20 mg eCTD In-Dev N / A IOR
Ramipril Capsule 1.25, 2.5, 5, 10mg CTD Ready UK MRP underway: UK
Ramipril Tablet 1.25, 2.5, 5, 10mg eCTD In-Dev N / A IOR
Ramipril + HCTZ Tablet2.5 mg + 12.5 mg, 5 mg + 12.5 mg, 5 mg + 25 mg
eCTD In-Dev N / A IOR
Risperidone Tablet 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg CTD Ready IOR DCP underway
Sertraline Tablet 50 mg, 100 mg CTD Ready UK MRP underway: UK
Sevelamer Tablet 400 mg, 800 mg eCTD In-Dev N / A IOR
Simvastatin Tablet 10 mg, 20 mg, 40 mg, 80 mg CTD Ready UK MRP underway: UK
Tianeptine Tablet 12.5 mg eCTD In-Dev N / A IOR
Tobramycin + Dexamethasone Drops - Eye 0.3%/0.1% eCTD In-Dev N / A IOR
Tolterodine Capsule - XR 2 mg, 4 mg eCTD In-Dev N / A IOR
Topiramate Tablet 25 mg, 50 mg, 100 mg, 200 mg CTD Ready France DCP underway
Tramadol + Paracetamol Tablet 37.5 mg + 325 mg eCTD In-Dev N / A IOR
Trandolapril Capsule 0.5 mg, 1 mg, 2 mg, 4 mg CTD Ready France MRP underway: UK
Travoprost Drops - Eye 0.004% eCTD In-Dev N / A IOR
Travoprost + Timolol Drops - Eye (0.04 mg + 5 mg)/ml eCTD In-Dev N / A IOR
Trimetazidine Tablet - SR 35 mg eCTD Ready IOR DCP underway
Trospium Tablet 5, 10, 15, 20, 30mg eCTD In-Dev N / A IOR
Urapidil Capsule - XR 30 mg, 60 mg, 90 mg eCTD In-Dev N / A IOR
Valsartan Tablet 40 mg, 80 mg, 160 mg, 320 mg CTD Ready France DCP underway
Valsartan + HCTZ Tablet80 mg + 12.5 mg, 160 mg + 12.5 mg, 160 mg + 25 mg, 320 mg +25 mg
eCTD In-Dev N / A IOR
Venlafaxine Capsule - XR 37.5, 75, 150mg CTD Ready IOR DCP underway
Ziprasidone Capsule 20 mg, 40 mg, 60 mg, 80 mg eCTD In-Dev N / A IOR
LUPIN
45
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
COUNTRYSwitzerland
CITYOberwill
COMPANY NAMENaari
NAARI AG is focused in the female healthcare segment, specializing in female hormonal products in which we are fully integrated. We are producing key intermediates, API’s and finished hormonal formulationsCore Sales Territory: Global Regulated MarketsCore Operation: API Manufacture, Finished Dose Manufacture, Sales and MarketingContact Person: Mr Supreet Sharma; Business Development Manager
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Chlormadinone + EE Tablet 2 MG + 0.03 MG CTD In-Dev N / A DCP slot booked
Dienogest Tablet 2 MG CTD IOR N / A IOR
Dienogest + EE Tablet 2 MG + 0.03 MG CTD In-Dev N / A IOR
Disulfiram Tablet 200 MG & 500 MG CTD In-Dev N / ADCP slot booked (Apr 2012)
Levonorgestrel Tablet 0.75 MG CTD Ready N / A IOR
Levonorgestrel Tablet 1.5 MG CTD In-Dev N / A IOR
Levonorgestrel + EE Tablet 0.15 MG + 0.03 MG CTD In-Dev N / A IOR
Mifepristone Tablet 200 MG CTD In-Dev N / A IOR
Misoprostol Tablet 200 MCG CTD In-Dev N / A IOR
Norethisterone Tablet 5 MG CTD In-Dev N / A IOR
46
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
COUNTRYBelgium
CITYDiegem
COMPANY NAMENeogen
Neogen is a company dedicated to the development of injectable products. All products are manufactured in EU-GMP facilities, mainly in Europe. Neogen is looking for partners with a presence in the hospital market.
Core Sales Territory: Global Regulated MarketsCore Operation: Sales and Marketing, Finished Dose ManufactureContact Person: Mr Thomas Jacobsen; Licensing Director
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Diclofenac Drops - Eye 0.1 % (unitdose) NTA Ready Denmark PLG
Esomeprazole Injection - Powder 40 mg eCTD In-Dev N / A DCP slot booked
Fluconazole Injection - Solution 2 mg/ml (50 ml, 100 ml, 200 ml) eCTD Ready France PLG
Fucidic Acid Cream 2% eCTD Ready N / A DCP underway
Ipratropium Nebuler 0.125 g/ml (2 ml) eCTD Ready Denmark PLG
Ipratropium Nebuler 0.25 g/ml (0.5 ml, 1 ml, 2 ml) eCTD Ready Denmark PLG
Ipratropium + Salbutamol Inhaler 2,5 + 0,5 mg eCTD Ready Denmark PL <12months
Ketotifen Drops - Eye 0.25 mg/ml (unitdose) eCTD Ready Denmark IOR
Ofloxacin Drops - Eye 0.3% (unit & multidose) eCTD Ready Denmark PL <12months
Pantoprazol Injection - Powder 40 mg eCTD Ready Denmark PLG
Paracetamol Injection 10 mg/ml eCTD Ready IOR PLG
Paracetamol Tablet 500 mg, 650 mg, 1000 mg eCTD In-Dev N / A DCP slot booked
Prednisolone Tablet 2,5; 5, 10, 20, 25 mg eCTD Ready IOR PLG
Ropivacaine Powder 2 mg/ml, 5 mg/ml, 7.5 mg/ml, 10 mg/ml eCTD Ready N / A NRP
Sodium Chromoglycate Drops - Eye 2 % (unitdose) eCTD Ready Denmark PLG
Teicoplanin Powder 200 mg, 400 mg eCTD Ready N / A PL <12months
Tropicamide Drops - Eye 0.5% (5 ml) (unit & multidose) eCTD Ready Denmark PLG
Xylometazoline Spray - Nasal 0,5 & 1 mg/ml eCTD Ready Europe PLG
Xylometazoline + eteric oil Spray - Nasal 0,05 & 0,1 % eCTD Ready N / A PL <12months
47
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
COUNTRYFinland
CITYEspoo
COMPANY NAMEOrion
Orion Corporation develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. Orion has been building well-being for over 90 years.Orion’s clientele consists of healthcare service providers and professionals, such as doctors, pharmacies, hospitals, healthcare centers, clinics and laboratories. The core therapy areas in Orion’s product and research strategy are: central nervous system, oncology and critical care , and respira-tory medicines administered with the Easyhaler device. Orion has also a large portfolio of generic, off-patent prescription medicines, hospital treatments and self-care products. These products are sold mainly in Finland, other Nordic countries, the new EU countries and Germany. The subsidiary Fermion produces active pharmaceutical ingredients for both Orion and other pharmaceutical companies.Core Sales Territory: All of EuropeCore Operation: API Manufacture, Finished Dose Manufacture, Sales and Marketing, DistributionContact Person: Mr Marko Salo; VP (Marketing & Sales)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Propafenone Tablet - IR 150mg, 300mg eCTD Ready N/A DCP Slot booked
48
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
COUNTRYSwitzerland
CITYTicino
COMPANY NAMERivopharm
Rivopharm is a Swiss company located near Lugano in the Ticino area. The core business of the company is the development and manufacture of pharmaceutical products in the generic field.With a strong regulatory department, a well motivated and efficient Research & Development team and a modern factory, we are ready to provide a customer oriented approach towards Research and Development, registration and production, while maintain-ing the Swiss reputation of efficiency, high quality and reliability.
Core Sales Territory: All of EuropeCore Operation: Finished Dose Manufacture Contact Person: Mr Nico Pianta; Commercial Director
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Alfuzosin Tablet - SR 10 mg CTD Ready IOR PLG
Amiodarone Tablet 100 mg, 200 mg CTD Ready IOR PLG
Amisulpride Tablet 50 mg, 100 mg, 200 mg, 400 mg CTD Ready IOR PLG
Bisoprolol Tablet 5 mg, 10 mg CTD Ready IOR PLG
Citalopram Tablet 10 mg, 20 mg, 30 mg, 40 mg CTD Ready IOR PLG
Clindamycin Tablet 150 mg, 300 mg CTD Ready N / A DCP underway
Domperidone Tablet 10 mg CTD Ready IOR PLG
Gabapentin Capsule 100 mg, 300 mg, 400 mg CTD Ready IOR PLG
Gabapentin Tablet 600 mg, 800 mg CTD Ready IOR PLG
Lacidipine Tablet 2 mg, 4 mg, 6 mg CTD In-Dev N / A NRP
Levetiracetam Tablet 250 mg, 500 mg, 750 mg, 1000 mg CTD Ready N / A DCP slot booked
Milnacipram Capsule 25 mg, 50 mg CTD In-Dev N / A NRP
Moxifloxacin Tablet 400 mg CTD In-Dev N / A IOR
Nicorandil Tablet 10 mg, 20 mg CTD Ready IOR PLG
Repaglinide Tablet 0.5 mg, 1 mg, 2 mg CTD Ready IOR PLG
Ropinirole Tablet 0.25 mg, 0.5 mg, 1 mg, 2 mg, 5 mg CTD Ready IOR PLG
Tranexamic Acid Tablet 500 mg CTD Ready IOR PLG
Zolpidem Tablet 5 mg, 10 mg CTD Ready IOR PLG
49
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
COUNTRYPortugal
CITYAbrunheira
COMPANY NAMETechnimede
Tecnimede Group is a privately owned group of pharmaceutical companies dedicated to the development, registration, manufac-turing, promotion and sale of pharmaceutical products for human use. We have a strong position in the generic medicines market and a clear orientation to quality and technological innovation. Considering R&D activities as a key factor in our development strategy, Tecnimede Group has been distinguished by Portuguese governmental institutions for its investment of important financial resources in R&D Activities.Working with CROs in Spain and Canada, we have a large experience in conducting BD / BE studies and a portfolio of more then 75 generic medicines that are being registered (locally, by DCP or MRP Procedure) all over Europe and in several countries outside the European Union. Core Sales Territory: All of Europe, Regulated MarketCore Operation: Finished Dose Manufacturer, Sales and MarketingContact Person: Ms Rita Ferreira; Business Development Manager
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Acarbose Tablet 50mg and 100mg eCTD Ready Portugal IOR
Alendronate / Alendronic Acid Tablet - Film coated 70mg eCTD Ready Portugal IOR
Amlodipine Tablet 5mg and 10mg eCTD Ready Portugal IOR
Aripiprazole Tablet - Dispersible (ODT) 2mg/ 5mg/ 10mg/ 15mg/ 20mg and 30mg eCTD In-Dev N / A IOR
Aripiprazole Tablet 2mg/ 5mg/ 10mg/ 15mg/ 20mg and 30mg eCTD In-Dev N / A IOR
Azithromycin Powder - Infusion 500mg eCTD Ready Portugal IOR
Bicalutamide Tablet - Film coated 50mg and 150mg eCTD Ready Portugal IOR
Calcipotriol Cream 0,05mg/g eCTD In-Dev N / A IOR
Calcipotriol Ointment 0,05mg/g eCTD In-Dev N / A IOR
Calcipotriol Solution - Cutaneous 0,05mg/g eCTD In-Dev N / A IOR
Calcipotriol + Betametasone Dipropionate
Ointment 0,05mg/g + 0,5mg/g eCTD In-Dev N / A IOR
Candesartan Tablet 2mg/ 4mg/ 8mg/ 16mg and 32mg eCTD In-Dev N / A IOR
Candesartan + HCTZ Tablet8mg + 12,5mg/ 16mg + 12,5mg and 32 mg + 25mg
eCTD In-Dev N / A IOR
Captopril Tablet 25mg and 50mg eCTD Ready Portugal IOR
Carvedilol Tablet 6,25mg and 25mg eCTD Ready Portugal IOR
Celecoxib Capsule 100mg and 200mg eCTD In-Dev N / A IOR
Cinnarizine + Dimenhydrinate Tablet 60mg and 120mg eCTD In-Dev N / A IOR
50
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Ciprofloxacin Tablet - Film coated 250mg and 500mg eCTD Ready Portugal IOR
Ciprofloxacin Injection - Bottle 2mg/ml - 100ml and 200ml eCTD Ready Portugal IOR
Clopidogrel + Aspirin (ASA) Tablet 75mg + 75mg and 75mg + 100mg eCTD In-Dev N / A IOR
Clopidogrel Hydrogenbisulphat Tablet - Film coated 75mg eCTD Ready Portugal IOR
Donepezil Tablet - Film coated 5mg and 10mg eCTD Ready Portugal IOR
Enalapril + HCTZ Tablet 20mg + 12,5mg eCTD Ready Portugal IOR
Eplerenone Tablet - Film coated 25mg and 50mg eCTD In-Dev N / A IOR
Escitalopram Solution - Oral 10mg/ml and 20mg/ml eCTD Ready Portugal IOR
Escitalopram Tablet - Film coated 5mg/ 10mg/ 15mg and 20mg eCTD Ready Portugal IOR
Esomeprazole Powder - Infusion 40mg eCTD In-Dev N / A IOR
Ezetimibe + Sinvastatina Tablet - Film coated10mg + 10mg/ 10mg + 20mg/ 10mg + 40mg and 10mg + 80mg
eCTD In-Dev N / A IOR
Finasteride Tablet 5mg eCTD Ready Portugal IOR
Fluconazole Capsule 50mg/ 150mg and 200mg eCTD Ready Portugal IOR
Fosfomycine Injection - Solution 1g and 4g eCTD In-Dev N / A IOR
Fosfomycine Granules 2g and 3g eCTD In-Dev N / A IOR
Gabapentin Tablet 600mg and 800mg eCTD Ready Portugal IOR
Gabapentin Capsule 100mg/ 300mg and 400mg eCTD Ready Portugal IOR
Ibandronate / Ibandronic Acid Tablet - Film coated 50mg and 150mg eCTD In-Dev N / A IOR
Ibandronate / Ibandronic Acid Injection - Solution 3mg/ml eCTD In-Dev N / A IOR
Ibandronate / Ibandronic Acid Injection - Solution 1mg/ml (4ml and 6ml) eCTD In-Dev N / A IOR
Irbesartan Tablet - Film coated 75mg/ 150mg and 300mg eCTD Ready Portugal IOR
Irbesartan + HCTZ Tablet - Film coated150mg + 12,5mg/ 300mg + 12,5mg and 300mg + 25mg
eCTD Ready Portugal IOR
Latanoprost Drops - Eye 50mg/ml eCTD In-Dev N / A IOR
Latanoprost + Timolol Drops - Eye 50mg/ml + 5mg/ml eCTD In-Dev N / A IOR
Leflunomide Tablet - Film coated 10mg/ 20mg and 100mg eCTD In-Dev N / A IOR
TECHNIMEDE
51
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Letrozole Tablet - Film coated 2,5mg eCTD Ready Portugal IOR
Levetiracetam Tablet - Film coated 250mg/ 500mg/ 750mg and 1000mg eCTD Ready Portugal IOR
Levetiracetam Solution - Oral 100mg/ml (300ml) eCTD Ready Portugal IOR
Levodopa + Carbidopa + Entecapone Tablet - Film coated
50mg + 12,5mg + 200mg/ 75mg + 18,75mg + 200mg/ 100mg + 25mg + 200mg/ 125mg + 31,25mg + 200mg/ 150mg + 37,5mg + 200mg and 200mg + 50mg + 200mg
eCTD In-Dev N / A IOR
Levofloxacin Tablet - Film coated 5mg/ml eCTD Ready Portugal IOR
Levofloxacin Injection - Solution eCTD Ready Portugal IOR
Losartan Tablet - Film coated 50mg and 100mg eCTD Ready Portugal IOR
Losartan + HCTZ Tablet - Film coated50mg + 12,5mg/ 100mg + 12,5mg and 100mg + 25mg
eCTD Ready Portugal IOR
Memantine Tablet - Film coated 10mg eCTD Ready Portugal IOR
Memantine Tablet - Film coated 5mg/ 10mg/ 15mg and 20mg eCTD In-Dev N / A IOR
Midazolam Injection - Solution 15mg/3ml and 50mg/10ml eCTD In-Dev N / A IOR
Mirtazapine Tablet - Film coated 15mg/ 30mg and 45mg eCTD Ready Portugal IOR
Montelukast Tablet - Film coated 10mg eCTD Ready Portugal IOR
Montelukast Tablet - Chewable 4mg and 5mg eCTD Ready Portugal IOR
Mycophenelate Mofetil Tablet - Film coated 250mg and 500mg eCTD Ready Portugal IOR
Olanzapine Tablet - Film coated 5mg/ 7,5mg and 10mg eCTD Ready Portugal IOR
Ondansetron Injection - Solution 8mg/4ml eCTD Ready Portugal IOR
Oxcarbazepine Tablet - Film coated 300mg and 600mg eCTD Ready Portugal IOR
Pantoprazol Tablet - Gastro resistant 20mg and 40mg eCTD Ready Portugal IOR
Pantoprazol Injection - Powder 40mg eCTD In-Dev N / A IOR
Paracetamol Injection - Solution 10mg/ml eCTD Ready Portugal IOR
Pioglitazone Tablet 15mg/ 30mg and 45mg eCTD Ready Portugal IOR
Pioglitazone + Metformin Tablet - Film coated 15mg + 850mg eCTD In-Dev N / A IOR
Pravastatin Tablet 10mg/ 20mg and 40mg eCTD Ready Portugal IOR
TECHNIMEDE
52
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Pregabalin Capsule300mg/ 225mg/ 200mg/ 150mg/ 100mg/ 75mg/ 50mg and 25mg
eCTD In-Dev N / A IOR
Ranitidine Tablet - Film coated 150mg and 300mg eCTD Ready Portugal IOR
Rosuvastatin Ca Tablet - Film coated 5mg/ 10mg/ 20mg and 40mg eCTD In-Dev N / A IOR
Sertraline Tablet - Film coated 50mg and 100mg eCTD Ready Portugal IOR
Sildenafil Tablet - Film coated 25mg/ 50mg and 100mg eCTD Ready Portugal IOR
Tamoxifen Tablet 10mg and 20mg eCTD Ready Portugal IOR
Terbinafine Tablet 250mg eCTD Ready Portugal IOR
Topiramate Tablet - Film coated 25mg/ 50mg/ 100mg and 200mg eCTD Ready Portugal IOR
Valacyclovir Tablet - Film coated 250mg/ 500mg and 1000mg eCTD Ready Portugal IOR
Valsartan Tablet - Film coated 40mg/ 80mg/ 160mg and 320mg eCTD Ready Portugal IOR
Valsartan + HCTZ Tablet - Film coated80mg + 12,5mg/ 160mg + 12,5mg/ 160mg + 25mg/ 320mg + 12,5mg and 320mg + 25mg
eCTD Ready Portugal IOR
Zoledronic Acid Injection - Solution 5mg/100ml eCTD In-Dev N / A IOR
Zoledronic Acid Injection - Solution 4mg/5ml eCTD In-Dev N / A IOR
TECHNIMEDE
53
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
COUNTRYUnited Kingdom
CITYWrexham
COMPANY NAMEWockhardt
Wockhardt UK is a diverse pharmaceutical business and is a major supplier of healthcare products to the Retail Pharmacy, Hospital Pharmacy and Grocery sectors. A wholly owned subsidiary of Mumbai-based Wockhardt Ltd, thriving Export and Contract Manufac-turing Divisions are helping to contribute to the company’s growth.Core Sales Territory: Global Regulated MarketsCore Operation: API Manufacture, API Manufacture, Finished Dose Manufacture, Finished Dose Manufacture, Sales and Market-ing, Sales and Marketing, DistributionContact Person: Mr Sanjeev Gulati; Director of In-Licensing
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Acetylsalicylic Acid Tablet 75 mg, 100 mg CTD Ready IOR IOR
Aciclovir Injection - Powder 250 mg CTD Ready IOR IOR
Aciclovir Tablet 200 mg, 400 mg, 800 mg CTD Ready IOR IOR
Aciclovir Cream 0.05 CTD In-Dev N / A IOR
Alendronate / Alendronic Acid Tablet 70 mg CTD Ready IOR IOR
Allopurinol Tablet 100 mg, 300 mg CTD Ready IOR IOR
Amiloride Tablet 5 mg CTD Ready IOR IOR
Amitriptyline Solution - Oral 10mg/5ml, 25mg / 5ml, 50mg/5ml CTD In-Dev N / A IOR
Amitriptyline Tablet 10 mg, 25 mg, 50 mg CTD Ready IOR IOR
Amlodipine Tablet 5 mg, 10 mg CTD Ready IOR IOR
Amoxicillin Capsule 250 mg, 500 mg CTD Ready IOR IOR
Amoxicillin Injection - Powder 250 mg, 500 mg, 1000 mg CTD Ready IOR IOR
Amoxicillin + Clavulanic Acid Powder 500 mg + 100 mg, 1000 mg + 200 mg CTD Ready IOR IOR
Aqueous Cream Cream 100gm, 500gm CTD In-Dev N / A IOR
Aspirin Tablet - Gastro resistant 75mg CTD In-Dev N / A IOR
Aspirin Tablet 300mg CTD In-Dev N / A IOR
Atenolol Tablet 25 mg, 50 mg, 100 mg CTD Ready IOR IOR
Atenolol + Chlortalidone Tablet 50 +12.5 mg, 100 + 25 mg CTD Ready IOR IOR
Atropine Sulphate Tablet 600mcg CTD Ready IOR IOR
54
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Bendroflumethazide Tablet 2.5 mg, 5 mg CTD Ready IOR IOR
Cefotaxime Injection - Powder 500mg, 1 g, 2 g CTD Ready IOR IOR
Ceftazidime Injection - Powder 1 g, 2 g CTD Ready IOR IOR
Ceftriaxone Injection - Powder 1 g, 2 g CTD Ready IOR IOR
Cetirizine Tablet 10 mg CTD Ready IOR IOR
Cetirizine Solution - Oral 5mg/5ml CTD In-Dev N / A IOR
Chlorpromazine Solution - Oral 25mg/5ml CTD In-Dev N / A IOR
Ciprofloxacin Tablet 250 mg, 500 mg CTD Ready IOR IOR
Citalopram Tablet 10mg, 20mg, 40mg CTD In-Dev N / A IOR
Clomifene Tablet 50 mg CTD Ready IOR IOR
Clopidogrel Tablet - Film coated 75mg CTD In-Dev N / A IOR
Co-Amilofruse (Amiloride + Furosemide) Tablet 2.5 / 20 mg, 5 / 40 mg, 10 / 80 mg CTD Ready IOR IOR
Co-Amilozide (Amiloride + HCTZ) Tablet 2.5 / 25 mg, 5 / 50 mg CTD Ready IOR IOR
Co-Amoxiclav Injection - Powder 600mg, 1.2g CTD In-Dev N / A IOR
Co-Codamol (Codeine + Paracetamol) Capsule 8/500mg, 30 / 500 mg CTD Ready IOR IOR
Co-Codamol (Codeine + Paracetamol) Tablet 30/500mg CTD In-Dev N / A IOR
Co-Danthramer Solution - Oral 25/200 / 5ml, 75/100 / 5ml CTD In-Dev N / A IOR
Codeine Linctus Solution - Oral 15mg/5ml CTD In-Dev N / A IOR
Codeine Phosphate Tablet 15 mg, 30 mg, 60 mg CTD Ready IOR IOR
Co-Dydramol Tablet 10 / 500 mg CTD Ready IOR IOR
Co-Fluampicil (Flucloxacillin + Ampicillin) Capsule 250mg/250mg CTD Ready IOR IOR
Co-Fluampicil (Flucloxacillin + Ampicillin) Injection - Powder 500 mg CTD Ready IOR IOR
Co-Fluampicil (Flucloxacillin + Ampicillin) Suspension 250 mg / 5 ml CTD Ready IOR IOR
Colchicine Tablet 500 mg CTD Ready IOR IOR
Co-Tenidone Tablet 50mg / 12.5mg, 100mg / 25mg CTD In-Dev N / A IOR
Cyproterone Acetate Tablet 50 mg, 100 mg CTD Ready IOR IOR
Diamorphine Injection 5 mg, 10 mg, 30 mg, 100 mg, 500 mg CTD Ready IOR IOR
WOCKHARDT
55
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Diazepam Injection 10 mg in 2ml CTD Ready IOR IOR
Diazepam Tablet 2 mg, 5 mg, 10 mg CTD Ready IOR IOR
Diazepam Rectal tubes 2.5 mg, 5 mg, 10 mg CTD Ready IOR IOR
Dihydrocodeine Tablet 30 mg CTD Ready IOR IOR
Disodium Pamidronate Injection 15 mg in 1ml , 30mg in 2ml, 60mg in 4ml, 90mg in 6ml
CTD Ready IOR IOR
Dobutamine Injection 250 mg in 20 ml CTD Ready IOR IOR
Domperidone Tablet 10 mg CTD Ready IOR IOR
Donepezil HCl Tablet - Film coated 5 mg, 10 mg CTD In-Dev N / A IOR
Emulsifying Ointment Ointment 100gm, 500gm CTD In-Dev N / A IOR
Ephedrine Tablet 15 mg, 30 mg CTD Ready IOR IOR
Ergotamine + Cyclizine + Caffeine Tablet 2 mg + 50 mg + 100 mg CTD Ready IOR IOR
Erythromycin (EES) Suspension 125 mg / 5 ml, 250mg / 5ml, 500mg / 5ml CTD Ready IOR IOR
Ferrous Sulphate Tablet 200mg CTD In-Dev N / A IOR
Finasteride Tablet 5 mg CTD Ready IOR IOR
Flucloxacillin Injection - Powder 250mg, 500mg, 1g CTD In-Dev N / A IOR
Fluconazole Capsule 50 mg, 150mg, 200 mg CTD Ready IOR IOR
Fluoxetine Capsule 20 mg CTD Ready IOR IOR
Fluoxetine Solution - Oral 20mg / 5ml CTD In-Dev N / A IOR
Fluvoxamine Tablet 50 mg, 100 mg CTD Ready IOR IOR
Folic Acid (Vitamin B9) Solution - Oral 2.5 mg / 5 ml CTD Ready IOR IOR
Folic Acid (Vitamin B9) Tablet 5mg CTD In-Dev N / A IOR
Furosemide Injection 250mg/25ml, 20 mg / 2 ml CTD Ready IOR IOR
Furosemide Solution - Oral 20mg/5ml, 40mg/5ml, 50mg/5ml CTD Ready IOR IOR
Furosemide Tablet 20 mg, 40 mg CTD Ready IOR IOR
Glibenclamide Tablet 2.5 mg, 5 mg CTD Ready IOR IOR
Gliclazide Tablet 80 mg CTD Ready IOR IOR
WOCKHARDT
56
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Haloperidol Solution - Oral 5mg/5ml, 10mg/5ml CTD In-Dev N / A IOR
Heartburn & indigestion liquid (sugar-free - Aniseed)
Suspension - Oral 500ml CTD In-Dev N / A IOR
Heartburn & indigestion liquid (sugar-free - Peppermint)
Suspension - Oral 500ml CTD In-Dev N / A IOR
Heparin Calcium Injection 5000 IU /0.2 ml CTD Ready IOR IOR
Heparin Sodium Injection 1,000 I.U./ml, 5,000 I.U./ml, 10,000 I.U./ml, 20,000 I.U./ml, 25,000 I.U./ml, 12,5000 I.U./ml
CTD Ready IOR IOR
Heparin Sodium Flush Solution Injection 50 IU, 200 IU CTD Ready IOR IOR
Hyaluronidase Injection - Powder 1500 IU CTD Ready IOR IOR
Hydrocortisone Cream 0.01 CTD In-Dev N / A IOR
Hydrocortisone Ointment 0.01 CTD In-Dev N / A IOR
Hyoscine Hydrobromide Injection 400mcg, 600mcg CTD Ready IOR IOR
Hypurin® Bovine Isophane Insulin Injection 100 IU/ml CTD Ready IOR IOR
Hypurin® Bovine Isophane Insulin Injection - Cartridge 100 IU/ml CTD Ready IOR IOR
Hypurin® Bovine Lente Insulin Injection 100 IU/ml CTD In-Dev N / A IOR
Hypurin® Bovine Neutal Insulin Injection 100 IU/ml CTD In-Dev N / A IOR
Hypurin® Bovine Neutal Insulin Injection - Cartridge 100 IU/ml CTD In-Dev N / A IOR
Hypurin® Bovine Protamine Zinc Insulin Injection 100 IU/ml CTD In-Dev N / A IOR
Hypurin® NPH Insulin, Pork Injection 100 IU/ml CTD Ready IOR IOR
Hypurin® Porcine 30/70 Mix Insulin Injection 100 IU/ml CTD In-Dev N / A IOR
Hypurin® Porcine 30/70 Mix Insulin Injection - Cartridge 100 IU/ml CTD In-Dev N / A IOR
Hypurin® Porcine Isophane Insulin Injection 100 IU/ml CTD In-Dev N / A IOR
Hypurin® Porcine Isophane Insulin Injection - Cartridge 100 IU/ml CTD In-Dev N / A IOR
Hypurin® Porcine Neutral Insulin Injection 100 IU/ml CTD In-Dev N / A IOR
Hypurin® Porcine Neutral Insulin Injection - Cartridge 100 IU/ml CTD In-Dev N / A IOR
Hypurin® Regular Insulin, Pork Injection 100 IU/ml CTD Ready IOR IOR
WOCKHARDT
57
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Ibuprofen Tablet 200 mg, 400 mg CTD Ready IOR IOR
Ibuprofen Caplet 200mg CTD In-Dev N / A IOR
Ibuprofen Suspension - Oral 100mg/5ml CTD In-Dev N / A IOR
Ketoconazole Shampoo 0.02 CTD In-Dev N / A IOR
Ketoprofen Gel 2.5% CTD In-Dev N / A IOR
Levothyroxine Tablet 25mcg CTD Ready IOR IOR
Loperamide Capsule 2mg CTD In-Dev N / A IOR
Loratadine Syrup 5mg/5ml CTD In-Dev N / A IOR
Metformin Tablet 500 mg, 850 mg CTD Ready IOR IOR
Methadone Injection 10 mg/ml CTD Ready IOR IOR
Midazolam Injection 2 mg/ml CTD Ready IOR IOR
Mirtazapine Tablet 15 mg, 30 mg, 45 mg CTD Ready IOR IOR
Mirtazapine Tablet - Dispersible (ODT) 15 mg, 30 mg, 45 mg CTD In-Dev N / A IOR
Morphine Sulphate Injection 10 mg/ml, 15 mg/ml, 30 mg/ml CTD Ready IOR IOR
Mycophenelate Mofetil Tablet - Film coated 500 mg CTD In-Dev N / A IOR
Naloxone Injection 400mcg CTD Ready IOR IOR
Naproxen Tablet 250 mg, 500 mg CTD Ready IOR IOR
Nitrazepam Tablet 5 mg CTD Ready IOR IOR
Norethisterone Tablet 5 mg CTD Ready IOR IOR
Ondansetron Tablet 4 mg, 8 mg CTD Ready IOR IOR
Ondansetron Injection 4 mg / 2 ml, 8 mg / 4 ml CTD Ready IOR IOR
Oxycodone HCl Injection 10 mg/1ml, 20mg/2ml CTD Ready IOR IOR
Pantoprazol Tablet - Gastro resistant 20 mg, 40 mg CTD Ready IOR IOR
Paracetamol Tablet 500 mg CTD Ready IOR IOR
Paracetamol Caplet 500mg CTD In-Dev N / A IOR
Paracetamol Capsule 500mg CTD In-Dev N / A IOR
Paracetamol Elixir 120mg/5ml CTD In-Dev N / A IOR
WOCKHARDT
58
FEATURED DEVELOPERS Global Generic Product directory
Registration dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Paracetamol Suspension - Oral 120mg/5ml, 250mg/5ml CTD In-Dev N / A IOR
Paracetamol + Caffeine Tablet 500mg/65mg CTD In-Dev N / A IOR
Phenytoin Tablet 100 mg CTD Ready IOR IOR
Pholcodine Linctus Solution - Oral 5mg/5ml, 10mg/5ml CTD In-Dev N / A IOR
Piperacillin + Tazobactam Injection 2 g + 0.25 g, 4 g + 0.5 g CTD Ready IOR IOR
Prednisolone Tablet 1 mg, 5 mg CTD Ready IOR IOR
Propylthiouracil Tablet 50 mg CTD Ready IOR IOR
Protamine Sulphate Injection 50mg/5ml CTD Ready IOR IOR
Pyridoxine Tablet 500mg CTD In-Dev N / A IOR
Quinine Sulphate Tablet 300 mg CTD Ready IOR IOR
Risperidone Suspension - Oral 1 mg/ml CTD Ready IOR IOR
Risperidone Tablet - Film coated 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg CTD Ready IOR IOR
Ropinirole Tablet - Film coated 0.25mg, 0.5mg, 1mg, 2mg, 5mg CTD In-Dev N / A IOR
Salbutamol Syrup 2mh/5ml CTD In-Dev N / A IOR
Sertraline Tablet 50 mg, 100 mg CTD Ready IOR IOR
Simple Linctus Solution - Oral 114.29mg/5ml, 125mg/5ml, 500mg CTD In-Dev N / A IOR
Simvastatin Tablet 10mg, 20mg, 40mg, 80mg CTD In-Dev N / A IOR
Sodium Citrate Micro-Enema Solution - Rectal 5ml CTD In-Dev N / A IOR
Sodium Valproate Tablet 200mg,500mg CTD In-Dev N / A IOR
Sodium Valproate Solution - Oral 200mg/5ml CTD In-Dev N / A IOR
Sulfadiazine Tablet 500 mg CTD Ready IOR IOR
Sulpiride Tablet 200 mg, 400 mg CTD Ready IOR IOR
Sumatriptan Tablet 50mg, 100mg CTD In-Dev N / A IOR
Tamoxifen Tablet 10 mg, 20 mg, 40 mg CTD Ready IOR IOR
Tamsulosin Capsule - MR 400mcg CTD Ready IOR IOR
Terbinafine Tablet 250 mg CTD Ready IOR IOR
Timolol Drops - Eye 0.25%, 0.5% CTD In-Dev N / A IOR
WOCKHARDT
59
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Timolol Solution - Eye 0.25%, 0.5% CTD In-Dev N / A IOR
Trimethoprim Suspension 50 mg / 5 ml CTD Ready IOR IOR
Ursodeoxycholic Acid Tablet 300 mg CTD Ready IOR IOR
Vancomycin Injection 500 mg, 1g CTD Ready IOR IOR
Venlafaxine Capsule - MR 75mg, 150mg CTD In-Dev N / A IOR
WOCKHARDT
60
FEATURED DEVELOPERSGlobal Generic Product directory
IOR (Info on request) PL <12months (PL expected within 12 months) LM (Local Market) PLG (Product License Granted) NRP (No Regulatory Position)
COUNTRYGermany
CITYBöblingen
COMPANY NAMEWörwag
Wörwag R&D GmbH as affiliate of Wörwag Pharma has a focus on dossier development, registration and out licensing of generic / OTC drugs, predominantly anti diabetic, cardiovascular and CNS products. Core Sales Territory: Global Regulated MarketsCore Operation: Sales and Marketing Contact Person: Mrs Linda Strehle; Research & Development
MOLECULE NAME DOSE FORM DOSE STRENGTHDOSSIER FORMAT
DOSSIER STATUS
APPROVED COUNTRY
REGULATORY STATUS
Candesartan Tablet 2 mg, 4 mg, 8 mg, 16 mg, 32 mg CTD In-Dev N / ADCP underway (Oct 2010)
Candesartan + HCTZ Tablet8 mg + 12.5 mg, 16 mg + 12.5 mg, 32 mg + 12.5 mg, 32 mg + 25 mg
CTD In-Dev N / A DCP slot booked
Clopidogrel Tablet - Film coated 75 mg eCTD Ready Germany PLG
Donepezil Tablet - Film coated 5 mg, 10 mg eCTD Ready Germany PLG
Enalapril + HCTZ Tablet 20 mg + 12.5 mg CTD Ready Germany Approved
Galantamine Capsule - XR 8 mg, 16 mg, 24 mg CTD In-Dev N / A DCP slot booked
HCTZ (Hydrochlorothiazide) Tablet 12.5 mg, 25 mg CTD Ready Germany Approved
Levetiracetam Tablet - Film coated 250 mg, 500 mg, 750 mg, 1000 mg eCTD Ready N / ADCP underway (Sept 2010)
Losartan Tablet - Film coated 12.5 mg, 25 mg, 50 mg, 100 mg CTD Ready Germany PLG
Losartan + HCTZ Tablet - Film coated50 mg + 12.5 mg, 100 mg + 12.5 mg, 100 mg + 25 mg
CTD Ready Germany Approved
Pioglitazone Tablet 15 mg, 30 mg, 45 mg eCTD In-Dev N / ADCP underway (Oct 2010)
Silymarin Capsule 86.5 mg CTD Ready Germany PLG
Silymarin Capsule 86,5 mg CTD In-Dev N / A NRP
Torsemide Tablet 2.5 mg, 5 mg, 10 mg, 20 mg CTD Ready Germany Approved
Valsartan Tablet 40 mg, 80 mg, 160 mg, 320 mg CTD Ready Germany DCP underway
Xipamide Tablet 10 mg, 20 mg, 40 mg CTD Ready Germany Approved
Give us a brief >> We agree a list of companies & products >>
We get a licensing offer from them >> You take it from there
WE'LL DO THE WORK!TAKE THE EFFORT OUT OF IN-LICENSING
www.findapharma.com
� Regulatory filings, variations and license maintenance
� Dossier creation, formatting and auditing (NTA, CTD, eCTD, ANDA)
� Manufacturing GMP inspection preparation
� Manufacturing technical transfers
� Formulation development projects
Europe – North America – AustralasiaExpertise is offered both in-house and through industry leading partners.
Talk to us about your technical service requirements today.
CALL +44 (0)845 453 1376+1 (646) 374 4234
[email protected] dossiers are only promoted by Genericlicensing Limited; always consider international and local patent laws before local submission.
Services Offered
© Copyright 2008-2011
Email: [email protected] or Phone: +44 8707524105